UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

(Mark One)
☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~September 30, 2021

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number	Exact Name of Registrant as Specified in its Charter, Principal Office Address and Telephone Number	State of Incorporation or Organization	I.R.S. Employer Identification No.
001-32427	Huntsman Corporation 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	42-1648585
333-85141	Huntsman International LLC 10003 Woodloch Forest Drive The Woodlands, Texas 77380 (281) 719-6000	Delaware	87-0630358

Securities registered pursuant to Section 12(b) of the Act:

Registrant	Title of each class	Trading Symbol	Name of each exchange on which registered
Huntsman Corporation	Common Stock, par value $0.01 per share	HUN	New York Stock Exchange
Huntsman International LLC	NONE	NONE	NONE

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Huntsman Corporation	Yes ☒	No ☐
Huntsman International LLC	Yes ☒	No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Huntsman Corporation	Large accelerated filer ☒	Accelerated filer ☐	Non-accelerated filer ☐	Smaller reporting company ☐	Emerging growth company ☐
Huntsman International LLC	Large accelerated filer ☐	Accelerated filer ☐	Non-accelerated filer ☒	Smaller reporting company ☐	Emerging Growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Huntsman Corporation		☐
Huntsman International LLC		☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Huntsman Corporation	Yes ☐	No ☒
Huntsman International LLC	Yes ☐	No ☒

On ~~April 21,~~October 20, 2021, ~~221,686,798~~218,030,754 shares of common stock of Huntsman Corporation were outstanding and 2,728 units of membership interests of Huntsman International LLC were outstanding. There is no trading market for Huntsman International LLC’s units of membership interests. All of Huntsman International LLC’s units of membership interests are held by Huntsman Corporation.

This Quarterly Report on Form 10-Q presents information for two registrants: Huntsman Corporation and Huntsman International LLC. Huntsman International LLC is a wholly-owned subsidiary of Huntsman Corporation and is the principal operating company of Huntsman Corporation. The information reflected in this Quarterly Report on Form 10-Q is equally applicable to both Huntsman Corporation and Huntsman International LLC, except where otherwise indicated. Huntsman International LLC meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q and, to the extent applicable, is therefore filing this form with a reduced disclosure format.

Table of Contents

Certain information set forth in this report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; projected impact of COVID-19 on our operations and future financial results; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions, divestitures, business separations, spin-offs, or other distributions, strategic opportunities, securities offerings, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into; new or modified laws, regulations and accounting pronouncements; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; foreign currency exchange rates and fluctuations in those rates; general economic and capital markets conditions; the timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that we intend or believe will or may occur in the future. In some cases, forward-looking statements can be identified by terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates” or “intends” or the negative of such terms or other comparable terminology, or by discussions of strategy. We may also make additional forward-looking statements from time to time. All such subsequent forward-looking statements, whether written or oral, by us or on our behalf, are also expressly qualified by these cautionary statements.

All forward-looking statements, including without limitation any projections derived from management’s examination of historical operating trends, are based upon our current expectations and various assumptions. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them, but there can be no assurance that management’s expectations, beliefs and projections will be achieved. All forward-looking statements apply only as of the date made. We undertake no obligation to publicly update or revise forward-looking statements whether because of new information, future events or otherwise, except as required by securities and other applicable law.

There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in or contemplated by this report. Any forward-looking statements should be considered in light of the risks set forth in “Part II. Item 1A. Risk Factors” below and “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020.

Huntsman Corporation Stockholders' Equity

Accumulated

Shares

Additional

Unearned

other

Noncontrolling

Common

Common

paid-in

Treasury

stock-based

Retained

comprehensive

interests in

Total

stock

stock

capital

stock

compensation

earnings

loss

subsidiaries

equity

Balance, January 1, 2020
224,295,868 $ 3 $ 4,008 $ (635 ) $ (17 ) $ 690 $ (1,362 ) $ 137 $ 2,824
Net income
— 0 0 0 0 705 0 3 708
Other comprehensive loss
— 0 0 0 0 0 (21 ) 0 (21 )
Issuance of nonvested stock awards
— 0 18 0 (18 ) 0 0 0 0
Vesting of stock awards
943,026 0 4 0 0 0 0 0 4
Recognition of stock-based compensation
— 0 2 0 5 0 0 0 7
Repurchase and cancellation of stock awards
(283,975 ) 0 0 0 0 (6 ) 0 0 (6 )
Stock options exercised
57,209 0 2 0 0 (2 ) 0 0 0
Treasury stock repurchased
(5,364,519 ) 0 0 (96 ) 0 0 0 0 (96 )
Dividends declared on common stock ($0.1625 per share)
— 0 0 0 0 (37 ) 0 0 (37 )
Balance, March 31, 2020
219,647,609 $ 3 $ 4,034 $ (731 ) $ (30 ) $ 1,350 $ (1,383 ) $ 140 $ 3,383

Table of Contents

~~As of March 31,~~For both September 30, 2021 and 2020, the amount of capital expenditures in accounts payable was $54 ~~million~~million. For the nine months ended September 30, 2021, the amount of cash paid for taxes in connection with the earnout provision achieved under the terms of the sales agreement of the India-based do-it-yourself (“DIY”) business was $3 million. See “Note 4. Discontinued Operations and ~~$59 million, respectively.~~Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business.”

910

Table of Contents

1011

Table of Contents

~~Table of Contents~~

Table of Contents

1415

Table of Contents

~~As of March 31,~~For both September 30, 2021 and 2020, the amount of capital expenditures in accounts payable was $54 ~~million~~million. For the nine months ended September 30, 2021, the amount of cash paid for taxes in connection with the earnout provision achieved under the terms of the sales agreement of the India-based DIY business was $3 million. See “Note 4. Discontinued Operations and ~~$59 million, respectively.~~ Business Dispositions—Sale of India-Based Do-It-Yourself Consumer Adhesives Business.”

1516

Table of Contents

For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” may be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary).

In this report, we may use, without definition, the common names of competitors or other industry participants. We may also use the common names or abbreviations for certain chemicals or products.

Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income (loss), financial position and cash flows for the periods presented. Results for interim periods are not necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2020 for our Company and Huntsman International.

We are a global manufacturer of differentiated organic chemical products. We operate in ~~four~~4 segments: Polyurethanes, Performance Products, Advanced Materials and Textile Effects. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining, synthetic fiber, textile chemicals and dyes industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride, epoxy-based polymer formulations, textile chemicals and dyes.

We operate our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in 1999.

Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our financial statements and Huntsman International’s financial statements relate primarily to the following:

Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.

~~Certain amounts in the condensed consolidated financial statements for the prior period have been reclassified to conform with the current presentation.~~

1617

Table of Contents

On ~~April 28, 2021,~~ ~~our Board of Directors declared a $0.1875 per share cash dividend on our common stock. This represents a 15% increase from the previous dividend.~~

On ~~January 15,~~July 1, 2021, we ~~completed~~entered into amendments to our U.S. accounts receivable securitization program (“U.S. A/R Program”) and our European accounts receivable securitization program (“EU A/R Program” and collectively with the ~~acquisition of Gabriel Performance Products, a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for~~U.S. A/R Program, “A/R Programs”) that, among other things, extended the coatings, adhesives, sealants and composite end-markets (“Gabriel Acquisition”), from funds affiliated with Audax Private Equity in an all-cash transaction of approximately $249 million, subject to customary closing adjustments, funded from available liquidity. The acquired business is being integrated into our Advanced Materials segment. See “Note 3. ~~Business Combinations and Acquisitions—Acquisition of Gabriel Performance Products.”~~

On ~~January 15, 2021,~~ ~~we redeemed in full~~ €~~445~~ ~~million (approximately $541 million) in aggregate principal amount~~scheduled termination dates of our ~~5.125% senior notes due~~A/R Programs from ~~2021~~April 2022 (~~“2021~~ ~~Senior Notes”) at the redemption price equal~~ to ~~100% of the principal amount of the notes, plus accrued and unpaid interest to, but~~ ~~not~~July 2024. ~~including, the redemption date. In connection with this redemption, we incurred an incremental cash tax liability of approximately $15 million in the~~ ~~first~~ ~~quarter of~~ ~~2021~~ ~~related to foreign currency exchange gains. See~~For additional information, see “Note 8. Debt—~~Senior Notes.~~Direct and Subsidiary Debt—A/R Programs.”

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

We adopted the following accounting pronouncement during 2021, which did not have a significant impact on our condensed consolidated financial statements:

~~As discussed in “Note~~On 1.January 15, 2021, ~~General—Recent Developments—Acquisition~~we completed the acquisition of Gabriel Performance ~~Products”, we completed the Gabriel Acquisition,~~Products, a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets on ~~January 15, 2021,~~ (“Gabriel Acquisition”), from funds affiliated with Audax Private Equity in an all-cash transaction of approximately ~~$249~~$251 million, subject to customary closing ~~adjustments,~~adjustments. The purchase price was funded from available ~~liquidity. The~~liquidity, and the acquired business is being integrated into our Advanced Materials segment. Transaction costs related to this acquisition were approximately $1nil and $2 million, respectively, for the three and ninemonths ended ~~March 31,~~September 30, 2021 and were recorded in other operating ~~(income) expense,~~income, net in our condensed consolidated statements of operations.

We ~~have~~ accounted for the Gabriel Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The preliminary allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

1718

Table of Contents

The acquisition cost allocation is preliminary pending final determination of the fair value of assets acquired and liabilities assumed, including final valuation of certain liabilities, property, plant and equipment, intangible assets, leases and deferred taxes. Intangible assets acquired included in this preliminary allocation consist primarily of trademarks, technology and trade secrets. The applicable amortization periods are still being assessed. For purposes of this preliminary allocation of fair value, we have assigned any excess of the acquisition cost over the estimated preliminary fair value to goodwill. The estimated goodwill recognized is attributable primarily to projected future profitable growth in our Advanced Materials specialty portfolio and synergies. We expect that a portion of the estimated goodwill arising from the acquisition will be deductible for income tax purposes, but the amount is still being assessed. It is possible that material changes to this preliminary allocation of acquisition cost could occur.

The acquired business had revenues and net income of ~~$23~~$81 million and $4$14 million, respectively, for the period from the date of acquisition to ~~March 31, 2021.~~September 30, 2021.

On May 18, 2020, we completed our acquisition of CVC Thermoset Specialties, a North American specialty chemical manufacturer serving the industrial composites, adhesives and coatings markets (“CVC Thermoset Specialties Acquisition”). We acquired the business for $304 million from Emerald Performance Materials LLC, which is majority owned by affiliates of American Securities LLC, ~~subject to customary closing adjustments,~~ in an all-cash transaction funded from available liquidity. The acquired business ~~is being~~was integrated into our Advanced Materials segment.

We ~~have~~ accounted for the CVC Thermoset Specialties Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The ~~preliminary~~ allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

The acquisition cost allocation is preliminary pending final determination of the fair value of assets acquired and liabilities assumed, primarily relating to the final valuation of certain liabilities and deferred taxes. Intangible assets acquired ~~included in this preliminary allocation~~ consist primarily of trademarks, trade secrets and customer relationships, which are predominantly being amortized over a period of 20 years. ~~For purposes of this preliminary allocation of fair value, we have assigned any excess of the acquisition cost over the estimated preliminary fair value to goodwill.~~ The ~~estimated~~ goodwill recognized is attributable primarily to projected future profitable growth in our Advanced Materials specialty portfolio and synergies. ~~We expect that~~ ~~none~~None of the ~~estimated~~ goodwill arising from the acquisition ~~will be~~is deductible for income tax purposes. ~~It is possible that material changes to this preliminary allocation of acquisition cost could occur.~~

1819

Table of Contents

On February 20, 2020, we completed our acquisition of Icynene-Lapolla, a leading North American manufacturer and distributor of spray polyurethane foam insulation systems for residential and commercial applications (“Icynene-Lapolla Acquisition”). We acquired the business from an affiliate of FFL Partners, LLC for $353 million in an all-cash transaction funded from available liquidity. The acquired business was integrated into our Polyurethanes segment.

We ~~have~~ accounted for the Icynene-Lapolla Acquisition using the acquisition method. As such, we analyzed the fair value of tangible and intangible assets acquired and liabilities assumed. The allocation of acquisition cost to the assets acquired and liabilities assumed is summarized as follows (dollars in millions):

As a result of the ~~finalization of the~~final valuation of the assets and liabilities, reallocations were made during the first quarter of 2021 in certain current asset and liability, property, plant and equipment, intangible asset, goodwill, other noncurrent assets and deferred tax balances. Intangible assets acquired consist primarily of trademarks, trade secrets and customer relationships, which are predominantly being amortized over a period of 10 years. The goodwill recognized is attributable primarily to projected future profitable growth, penetration into downstream markets and synergies. None of the goodwill arising from the acquisition is deductible for income tax purposes.

If the Gabriel Acquisition, the CVC Thermoset Specialties Acquisition and the Icynene-Lapolla Acquisition were to have occurred on January 1, 2020, the following estimated pro forma revenues, net (loss) income, net (loss) income attributable to Huntsman Corporation and Huntsman International would have been reported (dollars in millions):

1920

Table of Contents

On January 3, 2020, we completed the sale of our chemical intermediates businesses, which ~~includes~~included PO/MTBE, and our surfactants business (“Chemical Intermediates Businesses”) to Indorama Ventures Holdings L.P. (“Indorama”) in a transaction valued at approximately $2 billion, comprised of a cash purchase price of approximately $1.92 billion and the transfer of approximately $72 million in net underfunded pension and other post-employment benefit liabilities. In connection with this sale, we recognized a net after-tax gain of ~~$758~~$748 million in the first ~~quarter~~nine months of 2020. Also, in connection with this sale, we entered into long-term supply agreements with Indorama ~~for~~to supply us with certain raw materials at market ~~prices supplied by the Chemical Intermediates Businesses.~~prices.

The following table reconciles major line items constituting pretax income of discontinued operations to after-tax income of discontinued operations as presented in our condensed consolidated statements of operations (dollars in millions):

2021

Table of Contents

~~Inventories are stated~~We state our inventories at the lower of cost or market, with cost determined using ~~LIFO,~~last-in first-out (“LIFO”), first-in first-out and average cost methods for different components of inventory. Inventories consisted of the following (dollars in millions):

~~As of~~For both ~~March 31,~~September 30, 2021 and December 31, 2020, approximately ~~6% and~~ 7%~~, respectively,~~ of inventories were recorded using the LIFO cost ~~method, respectively.~~method.

We evaluate our investments and transactions to identify variable interest entities for which we are the primary beneficiary. We hold a variable interest in the following joint ventures for which we are the primary beneficiary:

During the ~~three~~nine months ended September 30, 2021, there were no changes in our variable interest entities.

Creditors of these entities have no recourse to our general credit. See “Note 8. Debt—Direct and Subsidiary Debt.” As the primary beneficiary of these variable interest entities at ~~March 31,~~September 30, 2021, the joint ventures’ assets, liabilities and results of operations are included in our condensed consolidated financial statements.

The following table summarizes the carrying amount of our variable interest entities’ assets and liabilities included in our condensed consolidated balance sheet as of ~~March 31,~~September 30, 2021 and our consolidated balance sheet as of December 31, 2020 (dollars in millions):

The revenues, income from continuing operations before income taxes and net cash provided by operating activities for our variable interest entities for the three and ninemonths ended ~~March 31,~~September 30, 2021 and 2020 are as follows (dollars in millions):

2122

Table of Contents

7. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTS

As of ~~March 31,~~September 30, 2021and December 31, 2020, accrued restructuring costs by type of cost and initiative consisted of the following (dollars in millions):

	*Workforce reductions*			*Demolition and decommissioning*		*Non-cancelable lease and contract termination costs*		*Other restructuring costs*			*Total*			*Workforce reductions*			*Non-cancelable lease and contract termination costs*		*Other restructuring costs*			*Total*
Accrued liabilities as of January 1, 2021	$	29		$	0	$	2	$	0		$	31		$	29		$	2	$	—		$	31
2021 charges for 2020 and prior initiatives		12			0		0		2			14			13			—		5			18
2021 charges for 2021 initiatives		2			0		0		0			2			2			—		—			2
2021 payments for 2020 and prior initiatives		(5	)		0		0		(2	)		(7	)		(12	)		—		(4	)		(16	)
Accrued liabilities as of March 31, 2021	$	38		$	0	$	2	$	0		$	40
2021 payments for 2021 initiatives															(1	)		—		—			(1	)
Accrued liabilities as of September 30, 2021														$	31		$	2	$	1		$	34

Details with respect to our reserves for restructuring, impairment and plant closing costs by segment and initiative are provided below (dollars in millions):

				*Performance*			*Advanced*			*Textile*			*Corporate*									*Performance*			*Advanced*			*Textile*			*Corporate*
	*Polyurethanes*			*Products*			*Materials*			*Effects*			*and Other*			*Total*			*Polyurethanes*			*Products*			*Materials*			*Effects*			*and Other*			*Total*
Accrued liabilities as of January 1, 2021	$	12		$	2		$	9		$	8		$	0		$	31		$	12		$	2		$	9		$	8		$	—		$	31
2021 charges (credits) for 2020 and prior initiatives		1			0			(1	)		0			14			14			5			1			(3	)		—			15			18
2021 charges for 2021 initiatives		0			0			2			0			0			2			—			—			2			—			—			2
2021 payments for 2020 and prior initiatives		(2	)		(1	)		(2	)		(1	)		(1	)		(7	)		(6	)		(2	)		(2	)		(3	)		(3	)		(16	)
Accrued liabilities as of March 31, 2021	$	11		$	1		$	8		$	7		$	13		$	40
2021 payments for 2021 initiatives																				—			—			(1	)		—			—			(1	)
Accrued liabilities as of September 30, 2021																			$	11		$	1		$	5		$	5		$	12		$	34

Current portion of restructuring reserves	$	11		$	1		$	5		$	4		$	5		$	26		$	11		$	1		$	4		$	2		$	5		$	23
Long-term portion of restructuring reserves		0			0			3			3			8			14			—			—			1			3			7			11

Details with respect to cash and noncash restructuring charges from continuing operations for the three and ninemonths ended ~~March 31,~~September 30, 2021 and 2020 are provided below (dollars in millions):

	*Three months*				*Three months*					*Nine months*
	*ended*				*ended*					*ended*
	*March 31,*				*September 30,*					*September 30,*
	*2021*		*2020*		*2021*			*2020*		*2021*			*2020*
Cash charges:
2021 charges for 2020 and prior initiatives	$	14	$	0	$	—		$	—	$	18		$	—
2021 charges for 2021 initiatives		2		0		—			—		2			—
2020 charges for 2019 and prior initiatives		0		1		—			—		—			3
2020 charges for 2020 initiatives		0		2		—			8		—			26
Noncash charges:
Other noncash charges		8		0
Accelerated depreciation						4			3		11			3
Gain on sale of assets						(3	)		—		(3	)		—
Other noncash (credits) charges						(2	)		1		6			2
Total restructuring, impairment and plant closing costs	$	24	$	3	$	(1	)	$	12	$	34		$	34

2021 Restructuring Activities

Beginning in the first quarter of 2021, our Corporate and other segment incurred restructuring costs related to a restructuring program to optimize our global approach to leveraging shared services capabilities. In connection with this restructuring program, we recorded restructuring expense of approximately ~~$14~~$16 million in the ~~first~~nine ~~quarter of~~months ended September 30, 2021 primarily related ~~primarily~~ to workforce reductions, and we expect to record further restructuring expenses of approximately $2$3 million through 2023.

Beginning in the third quarter of 2020, our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. In connection with this restructuring program, we recorded restructuring expense of approximately $1$4 million in the ~~first~~nine ~~quarter of~~months ended September 30, 2021 primarily related to workforce reductions and weaccelerated depreciation, partially offset by a gain on sale of assets of approximately $3 million. We expect to record further restructuring expenses of between approximately ~~$10~~$4 million and ~~$12~~$5 million through ~~year end~~the ~~2021.~~first half of 2022.

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs in connection with the CVC Thermoset Specialties Acquisition, the alignment of the segment’s commercial organization and optimization of the segment’s manufacturing processes. In connection with these restructuring programs, we recorded restructuring expense of approximately $8 million in the nine months ended September 30, 2021 primarily related to accelerated depreciation.

Table of Contents

2020 Restructuring Activities

~~During~~Beginning in the ~~first~~second quarter of2020, our Polyurethanes segment implemented a restructuring program to reorganize its spray polyurethane foam business to better position this business for efficiencies and growth in coming years. In connection with this restructuring program, we recorded restructuring expense of approximately $6 million in the nine months ended September 30, 2020 primarily related to workforce reductions and accelerated depreciation.

Beginning in the second quarter of 2020, our Performance Products segment implemented a restructuring program, primarily related to workforce reductions, in response to the sale of our Chemical Intermediates Businesses to Indorama. In connection with this restructuring program, we recorded restructuring expense of approximately $4 million in the nine months ended September 30, 2020.

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs, primarily related to workforce reductions, in connection with the CVC Thermoset Specialties Acquisition and the alignment of the segment's commercial organization and optimization of the segment's manufacturing processes. In connection with these restructuring programs, we recorded restructuring expense of approximately $10 million in the nine months ended September 30, 2020.

During 2020, our Textile Effects segment implemented restructuring programs to rationalize and realign structurally across various functions and certain locations within the segment. In connection with these restructuring programs, we recorded restructuring expense of approximately $2$10 million ~~for~~in the ~~three~~nine months ended ~~March 31,~~September 30, 2020, related primarily to workforce reductions.

~~Table of Contents~~

8. DEBT

~~Outstanding~~Our outstanding debt, net of debt issuance costs, consisted of the following (dollars in millions):

	*March 31,*		*December 31,*		*September 30,*		*December 31,*
	*2021*		*2020*		*2021*		*2020*
Senior Credit Facilities:
Revolving facility	$	0	$	0	$	0	$	0
Amounts outstanding under A/R programs		0		0		0		0
Senior notes		1,489		2,047		1,484		2,047
Variable interest entities		55		50		66		50
Other		23		24		33		24
Total debt	$	1,567	$	2,121	$	1,583	$	2,121
Total current portion of debt	$	57	$	593
Current portion of debt					$	16	$	593
Long-term portion of debt		1,510		1,528		1,567		1,528
Total debt	$	1,567	$	2,121	$	1,583	$	2,121

Direct and Subsidiary Debt

Huntsman Corporation’s direct debt and guarantee obligations consist of a guarantee of certain indebtedness incurred from time to time to finance certain insurance premiums. Substantially all of our other debt, including the facilities described below, has been incurred by our subsidiaries (primarily Huntsman International). Huntsman Corporation is not a guarantor of such subsidiary debt.

Certain of our subsidiaries have third-party debt agreements that contain certain restrictions with regard to dividends, distributions, loans or advances. In certain circumstances, the consent of a third party would be required prior to the transfer of any cash or assets from these subsidiaries to us.

Debt Issuance Costs

We record debt issuance costs related to a debt liability on the balance sheet as a reduction to the face amount of that debt liability. For ~~March 31,~~September 30, 2021 and December 31, 2020, the amount of debt issuance costs directly reducing the debt liability was $8$10 million and $9 million, respectively. We record the amortization of debt issuance costs as interest expense.

Revolving Credit Facility

As of ~~March 31,~~September 30, 2021, our $1.2 billion senior unsecured revolving credit facility (“Revolving Credit Facility”) was as follows ~~(dollars~~(monetary amounts in millions):

Unamortized

Discounts and

Committed

Principal

Debt Issuance

Carrying

Facility

Amount

Outstanding

Costs

Value

Interest Rate(2)

Maturity

Revolving Credit Facility

1,200

(1)

USD LIBOR plus 1.50%

2023

(1)	On ~~March 31,~~September 30, 2021, we had an additional $6$10 million (U.S. dollar equivalents) of letters of credit and bank guarantees issued and outstanding under our Revolving Credit Facility.

(2)	Interest rates on borrowings under the Revolving Credit Facility vary based on the type of loan and Huntsman International’s debt ratings. The ~~then applicable~~representative interest rate as of ~~March 31,~~September 30, 2021 was 1.50% above LIBOR.

Table of Contents

Term Loan Credit Facility

On September 24, 2019, Huntsman International entered into a 364-day term loan facility (the “2019 Term Loan”), pursuant to which Huntsman International borrowed an aggregate principal amount of €92 million (or $101 million equivalent). We used the net proceeds from the 2019 Term Loan to finance our acquisition of the 50% noncontrolling interest that we did not own in the Sasol-Huntsman maleic anhydride joint venture. On September 22, 2020, we repaid the 2019 Term Loan in full at maturity.

A/R Programs

Our ~~U.S. accounts receivable securitization program (“U.S.~~ A/R ~~Program”) and our European accounts receivable securitization program (“EU A/R Program” and collectively with the U.S. A/R Program, “A/R Programs”)~~Programs are structured so that we transfer certain of our trade receivables to the U.S. special purpose entity (“U.S. SPE”) and the European special purpose entity (“EU SPE”) in transactions intended to be true sales or true contributions. The receivables collateralize debt incurred by the U.S. SPE and the EU SPE.

On 23July 1, 2021,

~~Table~~we entered into amendments to our A/R Programs that, among other things, extended the respective scheduled termination dates of ~~Contents~~

our A/R Programs from April 2022 to July 2024.

Information regarding our A/R Programs as of ~~March 31,~~September 30, 2021 was as follows (monetary amounts in millions):

Maximum Funding

Amount

Maximum Funding

Amount

Facility

Maturity

Availability⁽¹⁾

Outstanding

Interest Rate⁽²⁾

Maturity

Availability(1)

Outstanding

Interest Rate⁽²⁾

U.S. A/R Program

April 2022

150

(3)

Applicable rate plus 0.90%

July 2024

150

(3)

Applicable rate plus 0.90%

EU A/R Program

April 2022

€

100

€

Applicable rate plus 1.30%

July 2024

€

100

€

Applicable rate plus 1.30%

(or approximately $118)

(or approximately $117)

(1)

The amount of actual availability under our A/R Programs may be lower based on the level of eligible receivables sold, changes in the credit ratings of our customers, customer concentration levels and certain characteristics of the accounts receivable being transferred, as defined in the applicable agreements.

(2)	The applicable rate for our U.S. A/R Program is defined by the lender as USD LIBOR. The applicable rate for our EU A/R Program is either ~~GBP LIBOR,~~ USD LIBOR or EURIBOR.

(3)	As of ~~March 31,~~September 30, 2021, we had approximately $5$7 million (U.S. dollar equivalents) of letters of credit issued and outstanding under our U.S. A/R Program.

As of ~~March 31,~~September 30, 2021 and December 31, 2020, ~~$245~~$336 million and $198 million, respectively, of accounts receivable were pledged as collateral under our A/R Programs.

Senior Notes

On January 15, 2021, weHuntsman International redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 5.125% senior notes due 2021 (“2021 Senior ~~Notes~~Notes”) at the redemption price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest to, but not including, the redemption date. In connection with this redemption, we incurred an incremental cash tax liability of approximately $15 million in the first quarter of 2021 related to foreign currency exchange gains.

On May 26, 2021, Huntsman International completed a $400 million offering of its 2031 Senior Notes. On June 23, 2021, Huntsman International applied the net proceeds from the offering, along with cash on hand, to redeem in full $400 million in aggregate principal amount of its 2022 Senior Notes and to pay accrued but unpaid interest of approximately $2 million. In addition, we paid redemption premiums and related fees and expenses of approximately $25 million and recognized a corresponding loss on early extinguishment of debt of $26 million in the second quarter of 2021.

The 2031 Senior Notes bear interest at 2.95% per year, payable semi‑annually on June 15 and December 15 of each year, and will mature on June 15, 2031. Huntsman International may redeem the 2031 Senior Notes in whole or in part at any time prior to March 15, 2031 at a price equal to 100% of the principal amount thereof plus a “make‑whole” premium as of, and accrued and unpaid interest, if any, to, but not including, the date of redemption. Huntsman International may redeem the 2031 Senior Notes at any time in whole or from time to time in part, on or after March 15, 2031 at a price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to, but not including, the date of redemption.

Variable Interest Entity Debt

On September 30, 2021, AAC, our consolidated 50%-owned joint venture, entered into a new term loan facility of 177 million SAR (approximately $47 million) with Saudi British Bank, of which approximately 104 million SAR (approximately $27 million) was funded with the remainder being funded subsequent to September 30, 2021. A portion of these funds were used to repay existing debt subsequent to September 30, 2021.

Note Payable from Huntsman International to Huntsman Corporation

~~During~~ During the first quarter of 2020, our intercompany loan of $380 million to our subsidiary Huntsman International was repaid to us in full.

Compliance with Covenants

We believe that we are in compliance with the covenants contained in the agreements governing our material debt instruments, including our Revolving Credit Facility, our A/R Programs and our senior notes.

Table of Contents

9. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We are exposed to market risks, such as changes in interest rates, foreign exchange rates and commodity prices. From time to time, we enter into transactions, including transactions involving derivative instruments, to manage certain of these exposures. We also hedge our net investment in certain European operations.

Our revenues and expenses are denominated in various foreign currencies, and our cash flows and earnings are thus subject to fluctuations due to exchange rate variations. From time to time, we may enter into foreign currency derivative instruments to minimize the short-term impact of movements in foreign currency rates. Where practicable, we generally net multicurrency cash balances among our subsidiaries to help reduce exposure to foreign currency exchange rates. Certain other exposures may be managed from time to time through financial market transactions, principally through the purchase of spot or forward foreign exchange contracts (generally with maturities of one year or less). We do not hedge our foreign currency exposures in a manner that would eliminate the effect of changes in exchange rates on our cash flows and earnings. As of ~~March 31,~~September 30, 2021, we had approximately ~~$162~~$178 million in notional amount (in U.S. dollar equivalents) outstanding in forward foreign currency contracts.

From time to time, we may purchase interest rate swaps and/or other derivative instruments to reduce the impact of changes in interest rates on our floating-rate exposures. Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount.

We review our non-U.S. dollar denominated debt and derivative instruments to determine the appropriate amounts designated as hedges. As of ~~March 31,~~September 30, 2021, we have designated approximately €~~155~~120 million (approximately ~~$183~~$140 million) of euro-denominated debt as a hedge of our net investment. For ~~both~~ the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and ~~March 31,~~September 30, 2020, the amount recognized on the hedge of our net investment was a gain of $8$7 million and ~~was~~a loss of $31 million, respectively, and were recorded in other comprehensive ~~loss~~income in our condensed consolidated statements of comprehensive income.

~~Table of Contents~~

10. FAIR VALUE

The fair values of financial instruments were as follows (dollars in millions):

	*March 31, 2021*						*December 31, 2020*						*September 30, 2021*						*December 31, 2020*
	*Carrying*			*Estimated*			*Carrying*			*Estimated*			*Carrying*			*Estimated*			*Carrying*			*Estimated*
	*Value*			*Fair Value*			*Value*			*Fair Value*			*Value*			*Fair Value*			*Value*			*Fair Value*
Non-qualified employee benefit plan investments	$	21		$	21		$	26		$	26		$	22		$	22		$	26		$	26
Investment in Venator		45			45			32			32			28			28			32			32
Option agreement for remaining Venator shares		(25	)		(25	)		11			11			(10	)		(10	)		11			11
Long-term debt (including current portion)		(1,567	)		(1,729	)		(2,121	)		(2,334	)		(1,583	)		(1,755	)		(2,121	)		(2,334	)

The carrying amounts reported in the balance sheets of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the immediate or short-term maturity of these financial instruments. Our investment in Venator is marked to fair value, which is obtained through market observable pricing using prevailing market prices (Level 1). Additionally, the estimated fair value of the option agreement related to the remaining ordinary shares we hold in Venator is based on a valuation technique using market observable inputs (Level 2). See “Note 4. Discontinued Operations and Business Dispositions—Sale of Venator Interest.” The fair values of non-qualified employee benefit plan investments are obtained through market observable pricing using prevailing market prices (Level 1). The estimated fair values of our long-term debt are based on quoted market prices for the identical liability when traded in an active market (Level 1). The fair value estimates presented herein are based on pertinent information available to management as of ~~March 31,~~September 30, 2021and December 31, 2020. Although ~~management is~~we are not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since ~~March 31,~~September 30, 2021, and current estimates of fair value may differ significantly from the amounts presented herein.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2021, there were no0 instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3), and there were no0 gains or losses (realized and unrealized) included in earnings for instruments categorized as Level 3 within the fair value hierarchy.

Table of Contents

11. REVENUE RECOGNITION

The following tables disaggregate our revenue from continuing operations by major source for the three months ended ~~March 31,~~September 30, 2021 and 2020 (dollars in millions):

			*Performance*		*Advanced*		*Textile*		*Corporate and*								*Performance*		*Advanced*		*Textile*		*Corporate and*
2021	*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*			*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*
Primary Geographic Markets(1)
U.S. and Canada	$	371	$	120	$	83	$	13	$	(3	)	$	584		$	537	$	183	$	90	$	14	$	(6	)	$	818
Europe		279		77		99		31		(3	)		483			377		106		108		29		(3	)		617
Asia Pacific		336		91		71		119		0			617			379		88		78		113		(1	)		657
Rest of world		82		17		25		30		(1	)		153			110		22		28		32		1			193
	$	1,068	$	305	$	278	$	193	$	(7	)	$	1,837		$	1,403	$	399	$	304	$	188	$	(9	)	$	2,285

Major Product Groupings
MDI urethanes	$	1,068										$	1,068		$	1,403										$	1,403
Differentiated			$	305									305				$	399									399
Specialty					$	245							245						$	276							276
Non-specialty						33							33							28							28
Textile chemicals and dyes							$	193					193								$	188					188
Eliminations									$	(7	)		(7	)									$	(9	)		(9	)
	$	1,068	$	305	$	278	$	193	$	(7	)	$	1,837		$	1,403	$	399	$	304	$	188	$	(9	)	$	2,285

			*Performance*		*Advanced*		*Textile*		*Corporate and*								*Performance*		*Advanced*		*Textile*		*Corporate and*
2020	*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*			*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*
Primary Geographic Markets(1)
U.S. and Canada	$	370	$	129	$	63	$	17	$	(7	)	$	572		$	350	$	104	$	52	$	12	$	(5	)	$	513
Europe		245		74		101		32		(1	)		451			253		57		70		20		0			400
Asia Pacific		199		70		56		103		0			428			264		63		57		86		0			470
Rest of world		74		19		21		28		0			142			69		14		20		24		0			127
	$	888	$	292	$	241	$	180	$	(8	)	$	1,593		$	936	$	238	$	199	$	142	$	(5	)	$	1,510

Major Product Groupings
MDI urethanes	$	888										$	888		$	936										$	936
Differentiated			$	292									292				$	238									238
Specialty					$	211							211						$	178							178
Non-specialty						30							30							21							21
Textile chemicals and dyes							$	180					180								$	142					142
Eliminations									$	(8	)		(8	)									$	(5	)		(5	)
	$	888	$	292	$	241	$	180	$	(8	)	$	1,593		$	936	$	238	$	199	$	142	$	(5	)	$	1,510

Table of Contents

The following tables disaggregate our revenue from continuing operations by major source for the nine months ended September 30, 2021 and 2020 (dollars in millions):

			*Performance*		*Advanced*		*Textile*		*Corporate and*
2021	*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*
Primary Geographic Markets(1)
U.S. and Canada	$	1,338	$	460	$	262	$	39	$	(15	)	$	2,084
Europe		949		283		317		95		(8	)		1,636
Asia Pacific		1,055		276		223		362		(1	)		1,915
Rest of world		284		56		79		92		0			511
	$	3,626	$	1,075	$	881	$	588	$	(24	)	$	6,146

Major Product Groupings
MDI urethanes	$	3,626										$	3,626
Differentiated			$	1,075									1,075
Specialty					$	795							795
Non-specialty						86							86
Textile chemicals and dyes							$	588					588
Eliminations									$	(24	)		(24	)
	$	3,626	$	1,075	$	881	$	588	$	(24	)	$	6,146

			*Performance*		*Advanced*		*Textile*		*Corporate and*
2020	*Polyurethanes*		*Products*		*Materials*		*Effects*		*Eliminations*			*Total*
Primary Geographic Markets(1)
U.S. and Canada	$	1,015	$	333	$	167	$	36	$	(16	)	$	1,535
Europe		681		184		243		71		(1	)		1,178
Asia Pacific		673		194		164		251		0			1,282
Rest of world		185		47		58		66		(1	)		355
	$	2,554	$	758	$	632	$	424	$	(18	)	$	4,350

Major Product Groupings
MDI urethanes	$	2,554										$	2,554
Differentiated			$	758									758
Specialty					$	561							561
Non-specialty						71							71
Textile chemicals and dyes							$	424					424
Eliminations									$	(18	)		(18	)
	$	2,554	$	758	$	632	$	424	$	(18	)	$	4,350

(1)	Geographic information for revenues is based upon countries into which product is sold.

2528

Table of Contents

Components of the net periodic benefit costs from continuing operations for the three and ninemonths ended ~~March 31,~~September 30, 2021 and 2020 were as follows (dollars in millions):

During the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, we made contributions to our pension and other postretirement benefit plans of ~~$14~~$45 million and ~~$20~~$73 million, respectively. During the remainder of 2021, we expect to contribute an additional amount of approximately ~~$42~~$9 million to these plans.

Table of Contents

On February 7, 2018 and on May 3, 2018, our Board of Directors collectively authorized us to repurchase up to an aggregate of $1 billion in shares of our common stock. The share repurchase program is supported by our free cash flow generation. Repurchases may be made through the open market, including through accelerated share repurchase programs, or in privately negotiated transactions, and repurchases may be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost. ~~During the~~ ~~first~~ ~~quarter of~~ ~~2020,~~ ~~we repurchased 5,364,519 shares of our common stock for approximately $96 million, excluding commissions, under the repurchase program.~~ Subsequent to the end of the first quarter of 2020, we suspended share repurchases under our existing share repurchase program in order to enhance our liquidity position in response to COVID-19. During the third quarter of 2021, we resumed the share repurchase program and repurchased 3,971,784 shares of our common stock for approximately $102 million, excluding commissions.

On April 28, 2021, our Board of Directors declared a $0.1875 per share cash dividend on our common stock. This represents a 15% increase from the previous dividend. During the quarters ended September 30, 2021 and September 30, 2020, we paid $42 million and $36 million, respectively, or $0.1875 and $0.1625 per share, respectively, to common stockholders. During the quarters ended June 30, 2021 and June 30, 2020, we paid $41 million and $36 million, respectively, or $0.1875 and $0.1625 per share, respectively, to common stockholders. During the quarters ended and March 31, 2021and March 31, 2020,, we paid $36 million and $37 million, respectively, or $0.1625 per share each to common stockholders.

The components of other comprehensive (loss) income and changes in accumulated other comprehensive loss by component were as follows (dollars in millions):

2730

Table of Contents

Three Months Ended March 31,

2021

2020

Amounts reclassified

Amounts reclassified

Affected line item in

from accumulated

from accumulated

the statement
Details about Accumulated Other

other

other

where net income
Comprehensive Loss Components(a): comprehensive loss comprehensive loss is presented
Amortization of pension and other postretirement benefits:

Prior service credit
$ (3 ) $ (3 )
(b)
Settlement loss 3 41 (c)
Actuarial loss
24 20
(b)(d)
24 58
Total before tax
(5 ) (14 )
Income tax expense
Total reclassifications for the period
$ 19 $ 44
Net of tax

2831

Table of Contents

Pension

Other

Foreign

and other

comprehensive

Amounts

Amounts

currency

postretirement

income of

attributable to

attributable to

translation

benefits

unconsolidated

noncontrolling

Huntsman

adjustment(a)

adjustments(b)

affiliates

Other, net

Total

interests

International

Beginning balance, January 1, 2020
$ (374 ) $ (1,012 ) $ 8 $ 0 $ (1,378 ) $ 26 $ (1,352 )
Other comprehensive (loss) income before reclassifications, gross
(67 ) 8 0 0 (59 ) 0 (59 )
Tax expense
(6 ) 0 0 0 (6 ) 0 (6 )
Amounts reclassified from accumulated other comprehensive loss, gross(c)
0 59 0 0 59 0 59
Tax expense
0 (14 ) 0 0 (14 ) 0 (14 )
Net current-period other comprehensive (loss) income
(73 ) 53 0 0 (20 ) 0 (20 )
Ending balance, March 31, 2020
$ (447 ) $ (959 ) $ 8 $ 0 $ (1,398 ) $ 26 $ (1,372 )

2932

Table of Contents

We are a party to various proceedings instituted by private plaintiffs, governmental authorities and others arising under provisions of applicable laws, including various environmental, products liability and other laws. Except as otherwise disclosed in this report, we do not believe that the outcome of any of these matters will have a material effect on our financial condition, results of operations or liquidity.

We may incur future costs for capital improvements and general compliance under environmental, health and safety (“EHS”) laws, including costs to acquire, maintain and repair pollution control equipment. For the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, our capital expenditures for EHS matters totaled $7$25 million and $6$17 million, respectively. Because capital expenditures for these matters are subject to evolving regulatory requirements and depend, in part, on the timing, promulgation and enforcement of specific requirements, our capital expenditures for EHS matters have varied significantly from year to year and we cannot provide assurance that our recent expenditures are indicative of future amounts we may spend related to EHS and other applicable laws.

We have accrued liabilities relating to anticipated environmental cleanup obligations, site reclamation and closure costs and known penalties. Liabilities are recorded when potential liabilities are either known or considered probable and can be reasonably estimated. Our liability estimates are calculated using present value techniques as appropriate and are based upon requirements placed upon us by regulators, available facts, existing technology and past experience. The environmental liabilities do not include amounts recorded as asset retirement obligations. We had accrued $5 million and $4 million for environmental liabilities ~~for both~~as of ~~March 31,~~September 30, 2021 and December 31, 2020., respectively. Of these amounts, $2 million and $1 million ~~was~~were classified as accrued liabilities in our condensed consolidated balance sheets ~~for both~~as of ~~March 31,~~September 30, 2021 and December 31, 2020, respectively, and $3 million was classified as other noncurrent liabilities in our condensed consolidated balance sheets ~~for~~as of both ~~March 31,~~September 30, 2021 and December 31, 2020~~, respectively.~~. In certain cases, our remediation liabilities may be payable over periods of up to 30 years. We may incur losses for environmental remediation in excess of the amounts accrued; however, we are not able to estimate the amount or range of such potential excess.

Under the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”) and similar state laws, a current or former owner or operator of real property in the U.S. may be liable for remediation costs regardless of whether the release or disposal of hazardous substances was in compliance with law at the time it occurred, and a current owner or operator may be liable regardless of whether it owned or operated the facility at the time of the release. Outside the U.S., analogous contaminated property laws, such as those in effect in France and Australia, can hold past owners and/or operators liable for remediation at former facilities. Currently, there are approximately nine former facilities or third-party sites in the U.S. for which we have been notified of potential claims against us for cleanup liabilities, including, but not limited to, sites listed under CERCLA. Based on current information and past experiences at other CERCLA sites, we do not expect these third-party claims to have a material impact on our condensed consolidated financial statements.

Under the Resource Conservation and Recovery Act (“RCRA”) in the U.S. and similar state laws, we may be required to remediate contamination originating from our properties as a condition to our hazardous waste permit. Some of our manufacturing sites have an extended history of industrial chemical manufacturing and use, including on-site waste disposal. We are aware of soil, groundwater or surface contamination from past operations at some of our sites, and we may find contamination at other sites in the future. For example, our Geismar, Louisiana facility is the subject of ongoing remediation requirements imposed under RCRA. Similar laws exist in a number of locations in which we currently operate, or previously operated, manufacturing facilities, such as Australia, India, France, Hungary and Italy.

The North Maybe Canyon Mine site is a CERCLA site and involves a former phosphorous mine near Soda Springs, Idaho, which is believed to have been operated by several companies, including a predecessor company to us. In 2004, the U.S. Forest Service notified us that we are a CERCLA potentially responsible party (“PRP”) for contamination originating from the site. In February 2010, we and Wells Cargo (another PRP) agreed to conduct a Remedial Investigation/Feasibility Study of a portion of the site and are currently engaged in that process. At this time, we are unable to reasonably estimate our potential liabilities at this site.

3033

Table of Contents

As of ~~March 31,~~September 30, 2021, we had approximately 67 million shares remaining under the stock-based compensation plans available for grant. Option awards have a maximum contractual term of 10 years and generally must have an exercise price at least equal to the market price of our common stock on the date the option award is granted. Outstanding stock-based awards generally vest annually over a three-year period.

The compensation cost from continuing operations under the stock-based compensation plans for our Company and Huntsman International were as follows (dollars in millions):

The total income tax benefit recognized in the condensed consolidated statements of operations for us and Huntsman International for stock-based compensation arrangements was $1$2 million and $3 million for ~~both of~~ the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020., respectively.

The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses the assumptions noted in the following table. Expected volatilities are based on the historical volatility of our common stock through the grant date. The expected term of options granted was estimated based on the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior. The risk-free rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of grant. The assumptions noted below represent the weighted average of the assumptions utilized for stock options granted during the periods.

A summary of stock option activity under the stock-based compensation plans as of ~~March 31,~~September 30, 2021 and changes during the ~~three~~nine months then ended is presented below:

3134

Table of Contents

The weighted-average grant-date fair value of stock options granted during the ~~three~~nine months ended ~~March 31,~~September 30, 2021 was $11.48 per option. As of ~~March 31,~~September 30, 2021, there was $9$6 million of total unrecognized compensation cost related to nonvested stock option arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately ~~2.1~~1.7 years.

The total intrinsic value of stock options exercised during the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was approximately $3$8 million and $1$4 million, respectively. Cash received from stock options exercised during each of the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was approximately $3$6 million and ~~nil,~~$2 million, respectively. The cash tax benefit from stock options exercised during each of the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was approximately $1$2 million and ~~nil,~~$1 million, respectively.

Nonvested shares granted under the stock-based compensation plans consist of restricted stock and performance share unit awards, which are accounted for as equity awards, and phantom stock, which is accounted for as a liability award because it can be settled in either stock or cash.

The fair value of each performance share unit award is estimated using a Monte Carlo simulation model that uses various assumptions, including an expected volatility rate and a risk-free interest rate. For the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, the weighted-average expected volatility rate was ~~44.8%~~44.9% and 34.0%, respectively, and the weighted average risk-free interest rate was 0.2% and 1.4%, respectively. For the performance share unit awards granted in the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, the number of shares earned varies based upon the Company achieving certain performance criteria over a three-year performance period. The performance criteria are total stockholder return of our common stock relative to the total stockholder return of a specified industry peer group for the three-year performance periods.

A summary of the status of our nonvested shares as of ~~March 31,~~September 30, 2021 and changes during the ~~three~~nine months then ended is presented below:

As of ~~March 31,~~September 30, 2021, there was ~~$47~~$36 million of total unrecognized compensation cost related to nonvested share compensation arrangements granted under the stock-based compensation plans. That cost is expected to be recognized over a weighted-average period of approximately ~~2.3~~2.0 years. The value of share awards that vested during the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was $18 million and ~~$23~~$24 million, respectively.

We use the asset and liability method of accounting for income taxes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial and tax reporting purposes. We evaluate deferred tax assets to determine whether it is more likely than not that they will be realized. Valuation allowances are reviewed on an individual tax jurisdiction basis to analyze whether there is sufficient positive or negative evidence to support a change in judgment about the realizability of the related deferred tax assets. These conclusions require significant judgment. In evaluating the objective evidence that historical results provide, we consider the cyclicality of our businesses and cumulative income or losses during the applicable period. Cumulative losses incurred over the applicable period limits our ability to consider other subjective evidence such as our projections for the future. Changes in expected future income in applicable jurisdictions could affect the realization of deferred tax assets in those jurisdictions.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, there was no0 tax benefit or expense recognized in connection with the net losses of ~~$19~~$28 million and ~~$110~~$100 million, respectively, on fair value adjustments to our Venator investment and related option to sell our remaining Venator shares recorded as part of non-operating income from continuing operations. As of December 31, 2019, we have recognized the portion of our Venator investment tax basis in excess of book that we ultimately expect to be able to utilize; therefore, no incremental tax benefit has been recognized on the year-to-date fair value losses incurred in 2020 or ~~2021~~2021. ~~year-to-date fair value losses.~~ As a significant, unusual and non-operating item, these amounts were treated discretely and excluded from the annual effective tax rate calculation for interim reporting.

We recorded income tax expense from continuing operations of ~~$34~~$114 million and $7$9 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

Huntsman International recorded income tax expense from continuing operations of ~~$35~~$115 million and $7$9 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, respectively. Our tax expense is significantly affected by the mix of income and losses in the tax jurisdictions in which we operate, as impacted by the presence of valuation allowances in certain tax jurisdictions.

Basic earnings per share excludes dilution and is computed by dividing net income attributable to Huntsman Corporation common stockholders by the weighted average number of shares outstanding during the period. Diluted earnings per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing net income attributable to Huntsman Corporation common stockholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities.

Basic and diluted earnings per share is determined using the following information (in millions):

Additional stock-based awards of ~~1.1~~approximately 1.0 million and ~~5.6~~3.8 million weighted average equivalent shares of stock were outstanding during the three months ended ~~March 31,~~September 30, 2021 and 2020, respectively, and approximately 1.5 million and 6.1 million weighted average shares of stock were outstanding during the nine months ended September 30, 2021 and 2020, respectively. However, these stock-based awards were not included in the computation of diluted earnings per share for the three and ninemonths ended ~~March 31,~~ September 30,2021and 2020 because the effect would be anti-dilutive.

3336

Table of Contents

We derive our revenues, earnings and cash flows from the manufacture and sale of a wide variety of differentiated and commodity chemical products. We have ~~four~~4 operating segments, which are also our reportable segments: Polyurethanes, Performance Products, Advanced Materials and Textile Effects. We have organized our business and derived our operating segments around differences in product lines.

Sales between segments are generally recognized at external market prices and are eliminated in consolidation. Adjusted EBITDA is presented as a measure of the financial performance of our global business units and for reporting the results of our operating segments. The adjusted EBITDA of our reportable operating segments excludes items that principally apply to our Company as a whole. The revenues and adjusted EBITDA from continuing operations for each of our reportable operating segments are as follows (dollars in millions):

3437

Table of Contents

Three months

ended

March 31,

2021

2020

Huntsman International:

Segment adjusted EBITDA(1):

Polyurethanes $ 207 $ 84
Performance Products 63 58
Advanced Materials 44 48
Textile Effects 25 20
Corporate and other(2) (47 ) (44 )
Total 292 166
Reconciliation of adjusted EBITDA to net income:

Interest expense, net—continuing operations (19 ) (20 )
Income tax expense—continuing operations (35 ) (7 )
Income tax expense—discontinued operations 0 (238 )
Depreciation and amortization—continuing operations (73 ) (67 )
Net income attributable to noncontrolling interests 17 3
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments (9 ) (13 )
EBITDA from discontinued operations(3) 1 1,015
Fair value adjustments to Venator investment (19 ) (110 )
Certain legal and other settlements and related expenses (2 ) (2 )
Gain on sale of businesses/assets 0 2
Income from transition services arrangements 1 0
Certain nonrecurring information technology project implementation costs (1 ) (1 )
Amortization of pension and postretirement actuarial losses (23 ) (18 )
Plant incident remediation costs (4 ) 0
Restructuring, impairment and plant closing and transition costs (24 ) (3 )
Net income $ 102 $ 707

3538

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

We operate in four segments: Polyurethanes, Performance Products, Advanced Materials and Textile Effects. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining, synthetic fiber, textile chemicals and dyes industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride, epoxy-based polymer formulations, textile chemicals and dyes. Our revenues from continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 were ~~$1,837~~$6,146 million and ~~$1,593~~$4,350 million, respectively.

On ~~April 28, 2021, our Board of Directors declared a $0.1875 per share cash dividend on our common stock. This represents a 15% increase from the previous dividend.~~

~~On January 15,~~July 1, 2021, we ~~completed~~entered into amendments to our A/R Programs that, among other things, extended the ~~Gabriel Acquisition in an all-cash transaction~~scheduled termination dates of ~~approximately $249 million, subject~~our A/R Programs from April 2022 to ~~customary closing adjustments, funded from available liquidity. The acquired business is being integrated into our Advanced Materials segment. See~~July 2024. For additional information, see “Note ~~3. Business Combinations~~8. Debt—Direct and ~~Acquisitions—Acquisition of Gabriel Performance Products”~~Subsidiary Debt—A/R Programs” to our condensed consolidated financial statements.

On January 15, 2021, we redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 2021 Senior Notes at the redemption price equal to 100% of the principal amount of the notes, plus accrued and unpaid interest to, but not including, the redemption date. In connection with this redemption, we incurred an incremental cash tax liability of approximately $15 million in the first quarter of 2021 related to foreign currency exchange gains. See “Note 8. Debt—Senior Notes” to our condensed consolidated financial statements.

3639

Table of Contents

In the ~~first~~third quarter of 2021, our adjusted effective tax rate was ~~23%~~15%. For 2021, our adjusted effective tax rate is expected to be approximately 19% to 20%, which is below our previously expected rate of approximately 22% to 24% due largely to tax benefits for increased export sales and services taxed at a U.S. income tax rate lower than 21%. We continue to expect our forward adjusted effective tax rate will be approximately 22% to 24%. For further information, see “—Non-GAAP Financial Measures” and “Note 18. Income Taxes” to our condensed consolidated financial statements.

Refer to “Forward-Looking Statements” for a discussion of our use of forward-looking statements in this Quarterly Report on Form 10-Q.

3740

Table of Contents

For each of our Company and Huntsman International, the following tables set forth the condensed consolidated results of operations (dollars in millions, except per share amounts):

3841

Table of Contents

3942

Table of Contents

4044

Table of Contents

Our condensed consolidated financial statements are prepared in accordance with GAAP, which we supplement with certain non-GAAP financial information. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and the reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in their entirety and not to rely on any single financial measure. These non-GAAP measures exclude the impact of certain income and expenses that we do not believe are indicative of our core operating results.

Our management uses adjusted EBITDA to assess financial performance. Adjusted EBITDA is defined as net income of Huntsman Corporation or Huntsman International, as appropriate, before interest, income tax, depreciation and amortization, net income attributable to noncontrolling interests and certain Corporate and other items, as well as eliminating the following adjustments: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) EBITDA from discontinued operations; (c) fair value adjustments to Venator investment; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related (income) expenses; ~~(e)~~(f) gain on sale of businesses/assets; ~~(f)~~(g) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(g)~~(h) certain nonrecurring information technology project implementation costs; ~~(h)~~(i) amortization of pension and postretirement actuarial losses; ~~(i)~~(j) plant incident remediation costs; and ~~(j)~~(k) restructuring, impairment and plant closing and transition costs. We believe that net income of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted EBITDA.

We believe adjusted EBITDA is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. However, this measure should not be considered in isolation or viewed as a substitute for net income of Huntsman Corporation or Huntsman International, as appropriate, or other measures of performance determined in accordance with U.S. GAAP. Moreover, adjusted EBITDA as used herein is not necessarily comparable to other similarly titled measures of other companies due to potential inconsistencies in the methods of calculation. Our management believes this measure is useful to compare general operating performance from period to period and to make certain related management decisions. Adjusted EBITDA is also used by securities analysts, lenders and others in their evaluation of different companies because it excludes certain items that can vary widely across different industries or among companies within the same industry. For example, interest expense can be highly dependent on a company’s capital structure, debt levels and credit ratings. Therefore, the impact of interest expense on earnings can vary significantly among companies. In addition, the tax positions of companies can vary because of their differing abilities to take advantage of tax benefits and because of the tax policies of the various jurisdictions in which they operate. As a result, effective tax rates and tax expense can vary considerably among companies. Finally, companies employ productive assets of different ages and utilize different methods of acquiring and depreciating such assets. This can result in considerable variability in the relative costs of productive assets and the depreciation and amortization expense among companies.

Nevertheless, our management recognizes that there are material limitations associated with the use of adjusted EBITDA in the evaluation of our Company as compared to net income of Huntsman Corporation or Huntsman International, as appropriate, which reflects overall financial performance. For example, we have borrowed money in order to finance our operations and interest expense is a necessary element of our costs and ability to generate revenue. Our management compensates for the limitations of using adjusted EBITDA by using this measure to supplement U.S. GAAP results to provide a more complete understanding of the factors and trends affecting the business rather than U.S. GAAP results alone.

4145

Table of Contents

Adjusted net income is computed by eliminating the after-tax amounts related to the following from net ~~(loss)~~ income attributable to Huntsman Corporation: (a) business acquisition and integration expenses and purchase accounting inventory adjustments; (b) ~~income~~loss (income) from discontinued operations; (c) fair value adjustments to Venator investment; (d) loss on early extinguishment of debt; (e) certain legal and other settlements and related (income) expenses; ~~(e)~~(f) gain on sale of businesses/assets; ~~(f)~~(g) income from transition services arrangements related to the sale of our Chemical Intermediates Businesses to Indorama; ~~(g)~~(h) certain nonrecurring information technology project implementation costs; ~~(h)~~(i) amortization of pension and postretirement actuarial losses; ~~(i)~~(j) plant incident remediation costs; and ~~(j)~~(k) restructuring, impairment and plant closing and transition costs. Basic adjusted net income per share excludes dilution and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period. Adjusted diluted net income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing adjusted net income by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities. Adjusted net income and adjusted net income per share amounts are presented solely as supplemental information.

We believe adjusted net income is useful to investors in assessing the businesses’ ongoing financial performance and provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends.

We believe free cash flow is an important indicator of our liquidity as it measures the amount of cash we generate. Management internally uses a free cash flow measure: (a) to evaluate our liquidity, (b) evaluate strategic investments, (c) plan stock buyback and dividend levels and (d) evaluate our ability to incur and service debt. Starting with the quarter ended March 31, 2020, we updated our definition of free cash flow to a presentation more consistent with today’s market standard of net cash provided by operating activities less capital expenditures. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures.

We believe that the effective tax rate of Huntsman Corporation or Huntsman International, as appropriate, is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. We believe our adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. We do not provide reconciliations for adjusted effective tax rate on a forward-looking basis because we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as business acquisition and integration expenses, merger costs, certain legal and other settlements and related costs, gains on sale of ~~business/~~businesses/assets and amortization of pension and postretirement actuarial losses. Each of such adjustments has not yet occurred, is out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

4246

Table of Contents

Three Months Ended ~~March 31,~~September 30, 2021 Compared with Three Months Ended ~~March 31,~~September 30, 2020

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of Chemical Intermediates Businesses” to our condensed consolidated financial statements, the results from continuing operations exclude the results of our Chemical Intermediates ~~and~~ Businesses and the results of our former polymers, base chemicals and Australian styrenics ~~business~~businesses for all periods presented. The increase of ~~$154~~$166 million in net income from continuing operations attributable to Huntsman Corporation and the increase of ~~$157~~$165 million in net income from continuing operations attributable to Huntsman International ~~from continuing operations, respectively,~~ was the result of the following items:

4347

Table of Contents

4448

Table of Contents

The increase in revenues in our Polyurethanes segment for the three months ended ~~March 31,~~September 30, 2021 compared to the same period of 2020 was largely due to higher MDI average selling ~~prices.~~prices and slightly higher sales volumes. MDI average selling prices increased ~~mostly~~ in ~~China and Europe. Even though~~all our regions. Sales volumes increased primarily due to stronger demand ~~was strong~~ in relation to the ~~first quarter~~ongoing recovery from the global economic slowdown, partially offset by the impact of ~~2021, overall volumes were largely flat and MDI volumes decreased because of a previously disclosed turnaround~~Hurricane Ida at our Geismar, Louisiana facility ~~some unplanned downtime resulting from the U.S. Gulf Coast Winter Storm Uri~~ that occurred in the ~~first~~third quarter of ~~2021 as well as the planned build up of inventory ahead of our scheduled maintenance outage at our Rotterdam, Netherlands facility.~~2021. The increase in segment adjusted EBITDA was primarily due to higher MDI margins resulting from higher MDI ~~pricing.~~pricing and slightly higher sales volumes as well as stronger earnings from our PO/MTBE joint venture in China, partially offset by higher raw material costs.

The increase in revenues in our Performance Products segment for the three months ended ~~March 31,~~September 30, 2021 compared to the same period of 2020 was primarily due to higher average selling prices ~~partially offset by lower~~and higher sales volumes. Average selling prices increased primarily due to stronger demand in relation to the ongoing recovery from the global economic slowdown as well as in response to an increase in raw material costs. Sales volumes ~~decreased~~also increased primarily due to stronger demand. The increase in segment adjusted EBITDA was primarily due to increased revenue and margins, partially offset by increased fixed costs.

The increase in revenues in our Advanced Materials segment for the three months ended September 30, 2021 compared to the same period in 2020 was primarily due to higher sales volumes, higher average selling prices and the favorable net impact of the Gabriel Acquisition and the sale of the India-based DIY business. See “Note 3. Business Combinations and Acquisitions” and “Note 4. Discontinued Operations and Business Dispositions” to our condensed consolidated financial statements. Excluding our recent acquisition and divestiture, sales volumes increased across all of our specialty markets, primarily in relation to the ongoing recovery from the global economic slowdown. Average selling prices increased largely in response to higher raw material costs. The increase in segment adjusted EBITDA was primarily due to higher sales volumes and the benefit from our recent acquisition.

The increase in revenues in our Textile Effects segment for the three months ended September 30, 2021 compared to the same period of 2020 was due to higher sales volumes and higher average selling prices. Sales volumes increased primarily due to increased demand resulting from the ongoing recovery from the global economic slowdown, particularly in the North Asia and Americas regions. Average selling prices increased primarily in response to higher freight and logistics costs. The increase in segment adjusted EBITDA was primarily due to higher sales revenues, partially offset by higher fixed costs.

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the three months ended September 30, 2021, adjusted EBITDA from Corporate and other for Huntsman Corporation decreased by $11 million to a loss of $48 million from a loss of $37 million for the same period of 2020. For the three months ended September 30, 2021, adjusted EBITDA from Corporate and other for Huntsman International decreased by $11 million to a loss of $47 million from a loss of $36 million for the same period of 2020. The decrease in adjusted EBITDA from Corporate and other was primarily due to a charge from a LIFO inventory valuation reserve adjustment and an increase in corporate overhead costs, partially offset by an increase in unallocated foreign currency exchange gains.

Table of Contents

Nine Months Ended September 30, 2021 Compared with Nine Months Ended September 30, 2020

As discussed in “Note 4. Discontinued Operations and Business Dispositions—Sale of Chemical Intermediates Businesses” to our condensed consolidated financial statements, the results from continuing operations exclude the results of our Chemical Intermediates and Businesses and the results of our former polymers, base chemicals and Australian styrenics business for all periods presented. The increase of $542 million in net income from continuing operations attributable to Huntsman Corporation and the increase of $545 million in net income from continuing operations attributable to Huntsman International was the result of the following items:

Table of Contents

The increase in revenues in our Polyurethanes segment for the nine months ended September 30, 2021 compared to the same period of 2020 was largely due to higher MDI average selling prices and higher sales volumes. MDI average selling prices increased mostly in China and Europe with increases in our Americas region during the third quarter of 2021. Sales volumes increased primarily due to stronger demand in relation to the ongoing recovery from the global economic slowdown, partially offset by some unplanned downtime resulting from the U.S. Gulf Coast Winter Storm Uri that occurred in the first quarter of 2021, the scheduled turnaround at our Rotterdam, Netherlands facility during the second quarter of 2021 and the impact of Hurricane Ida at our Geismar, Louisiana facility that occurred in the third quarter of 2021. The increase in segment adjusted EBITDA was primarily due to ~~lower~~higher MDI margins resulting from higher MDI pricing and higher sales volumes as well as stronger earnings from our PO/MTBE joint venture in China, partially offset by higher raw material costs

The increase in revenues in our Performance Products segment for the nine months ended September 30, 2021 compared to the same period of 2020 was primarily due to higher average selling prices and higher sales volumes. Average selling prices increased primarily due to stronger demand in relation to the ongoing recovery from the global economic slowdown as well as in response to an increase in raw material costs. Sales volumes also increased primarily due to stronger demand. The increase in segment adjusted EBITDA was primarily due to increased revenue and margins, partially offset by increased fixed costs.

The increase in revenues in our Advanced Materials segment for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 compared to the same period in 2020 was primarily due to higher sales volumes, higher average selling prices and the favorable net impact of the CVC Thermoset Specialties Acquisition, the Gabriel Acquisition and the ~~Gabriel Acquisition.~~sale of the India-based DIY business. See “Note 3. Business Combinations and Acquisitions” and “Note 4. Discontinued Operations and Business Dispositions” to our condensed consolidated financial statements. Excluding our recent acquisitions and divestiture and with the exception of our global aerospace business, sales volumes increased across all markets, primarily in relation to the ongoing recovery from the global economic slowdown. Average selling prices increased largely in response to higher raw material costs and due to the impact of a weaker U.S. dollar against major international ~~currencies and in response to higher raw material costs.~~currencies. The ~~decrease~~increase in segment adjusted EBITDA was primarily due to ~~lower aerospace~~higher sales volumes ~~partially offset by~~and the benefit from ~~the above mentioned~~our recent acquisitions.

The increase in revenues in our Textile Effects segment for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 compared to the same period of 2020 was primarily due to higher sales volumes ~~partially offset by lower~~and slightly higher average selling prices. Sales volumes increased primarily due to increased demand resulting from the ongoing recovery from the global economic ~~slowdown, particularly in Asia.~~slowdown. Average selling prices slightly increased primarily due to the impact of a weaker U.S. dollar against major international currencies. The increase in segment adjusted EBITDA was primarily due to higher sales revenues, ~~and lower~~partially offset by higher fixed costs.

Corporate and other includes unallocated corporate overhead, unallocated foreign currency exchange gains and losses, LIFO inventory valuation reserve adjustments, loss on early extinguishment of debt, unallocated restructuring, impairment and plant closing costs, nonoperating income and expense and gains and losses on the disposition of corporate assets. For the ~~three~~nine months ended ~~March 31,~~September 30, 2021, adjusted EBITDA from Corporate and other for Huntsman Corporation decreased by $5$32 million to a loss of ~~$50~~$146 million from a loss of ~~$45~~$114 million for the same period of 2020. For the ~~three~~nine months ended ~~March 31,~~September 30, 2021, adjusted EBITDA from Corporate and other for Huntsman International decreased by $3$30 million to a loss of ~~$47~~$140 million from a loss of ~~$44~~$110 million for the same period of 2020. The decrease in adjusted EBITDA from Corporate and other ~~resulted~~was primarily due to a charge from a ~~decrease in unallocated foreign currency exchange gains~~LIFO inventory valuation reserve adjustment and an increase in corporate overhead ~~costs.~~costs, partially offset by an increase in unallocated foreign currency exchange gains.

4552

Table of Contents

The following is a discussion of our liquidity and capital resources and does not include separate information with respect to Huntsman International in accordance with General Instructions H(1)(a) and (b) of Form 10-Q.

Cash Flows for the ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2021 Compared with ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2020

Net cash ~~used in~~provided by operating activities from continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was ~~$16~~$163 million and ~~$40~~$110 million, respectively. The ~~decrease~~increase in net cash ~~used in~~provided by operating activities from continuing operations during the ~~three~~nine months ended ~~March 31,~~September 30, 2021 compared with the same period in 2020 was primarily attributable to increased operating income as described in “—Results of Operations” above ~~partially offset by a $41 million unfavorable variance in operating assets and liabilities~~ for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 as compared with the same period of ~~2020.~~2020, partially offset by a $382 million unfavorable variance in operating assets and liabilities.

Net cash (used in) provided by investing activities ~~from continuing operations~~ for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was ~~$(323)~~$(439) million and ~~$1,511~~$1,105 million, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020, we paid ~~$98~~$250 million and ~~$61~~$170 million for capital expenditures, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2021, we received $43 million for the sale of businesses, primarily due to the receipt of $28 million pursuant to an earnout provision in connection with the sale of our India-based DIY business, and we paid $245 million for the acquisition of businesses, primarily related to approximately ~~$240~~$242 million paid for the Gabriel Acquisition, net of cash acquired. During the ~~three~~nine months ended ~~March 31,~~September 30, 2020, we received approximately $1.92 billion for the sale of our Chemical Intermediates Businesses, and we paid ~~$346~~$653 million ~~for~~in connection with the Icynene-Lapolla Acquisition and the CVC Thermoset Specialties Acquisition, net of cash acquired.

Net cash used in financing activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was ~~$579~~$809 million and ~~$354~~$546 million, respectively. During the ~~three~~nine months ended ~~March 31,~~September 30, 2021, we redeemed in full €445 million (approximately $541 million) in aggregate principal amount of our 2021 Senior Notes, and we redeemed in full $400 million in aggregate principal amount of our 2022 Senior Notes. Additionally, during the nine months ended September 30, 2021, we issued $400 million in aggregate principal amount of our 2031 Senior Notes and received borrowings of approximately 104 million SAR (approximately $27 million) related to funding on a new term loan facility of our consolidated 50%-owned joint venture, AAC. See “Note 8. Debt—Direct and Subsidiary Debt—Variable Interest Entity Debt” to our condensed consolidated financial statements. During the ~~three~~nine months ended ~~March 31,~~September 30, 2020, we ~~made repayments~~repaid a total of $153 million on our Revolving Credit ~~facility~~Facility and repaid in full $109 million on our 2019 Term Loan in the third quarter of ~~$158 million and repurchased common stock for $96 million.~~2020.

Free cash flow from continuing operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and 2020 was a use of cash of ~~$114~~$87 million and ~~$101~~$60 million, respectively.

The following information summarizes our working capital position (dollars in millions):

Our working capital decreased by ~~$263~~$138 million as a result of the net impact of the following significant changes:

4653

Table of Contents

See “Note 8. Debt—Direct and Subsidiary Debt” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—Debt Issuance Costs” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—Revolving Credit Facility” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—Term Loan Credit Facility” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—A/R Programs” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—Senior Notes” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—Variable Interest Entity Debt” to our condensed consolidated financial statements.

See “Note 8. Debt—Direct and Subsidiary Debt—Note Payable from Huntsman International to Huntsman Corporation” to our condensed consolidated financial statements.

See “Note 8. Debt—Compliance with Covenants” to our condensed consolidated financial statements.

4754

Table of Contents

We depend upon our cash, Revolving Credit Facility, A/R Programs and other debt instruments to provide liquidity for our operations and working capital needs. As of ~~March 31,~~September 30, 2021, we had ~~$2,064~~$1,955 million of combined cash and unused borrowing capacity, consisting of ~~$673~~$505 million in cash, ~~$1,194~~$1,190 million in availability under our Revolving Credit Facility and ~~$197~~$260 million in availability under our A/R Programs. We believe our existing cash balances, together with funds generated from operations and amounts available under our credit facility, will allow us to manage the anticipated impact of COVID-19 on our business operations for the foreseeable future. Our liquidity can be significantly impacted by various factors. The following matters ~~had, or~~ are expected to have a significant impact on our liquidity:

As of ~~March 31,~~September 30, 2021, we had ~~$57~~$16 million classified as current portion of debt, including debt at our variable interest entities of ~~$55~~$13 million and certain other short-term facilities and scheduled amortization payments totaling $2$3 million. We intend to renew, repay or extend the majority of these short-term facilities in the next twelve months.

As of ~~March 31,~~September 30, 2021, we had approximately ~~$398~~$365 million of cash and cash equivalents, including restricted cash, held by our foreign subsidiaries, including our variable interest entities. We intend to use cash held in our foreign subsidiaries to fund our local operations. Nevertheless, we could repatriate cash as dividends, which dividends would generally not be subject to U.S. taxation as a result of the U.S. Tax Reform Act. However, such repatriation may potentially be subject to ~~limited~~certain foreign withholding taxes.

4855

Table of Contents

Our management, with the participation of our chief executive officer and chief financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of ~~March 31,~~September 30, 2021. Based on this evaluation, our chief executive officer and chief financial officer have concluded that, as of ~~March 31,~~September 30, 2021, our disclosure controls and procedures were effective, in that they ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and (2) accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

No changes to our internal control over financial reporting occurred during the quarter ended ~~March 31,~~September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). However, we can only give reasonable assurance that our internal controls over financial reporting will prevent or detect material misstatements on a timely basis. Ineffective internal controls over financial reporting could cause investors to lose confidence in our reported financial information and could result in a lower trading price for our securities.

4956

Table of Contents

~~There~~Except as set forth below, there have been no material developments with respect to the legal proceedings referenced in Part I, Item 3 of our Annual Report on Form 10-K for the year ended December 31, 2020.

On February 6, 2017, we filed a lawsuit in New York state court against Rockwood Specialties Group, Inc., Rockwood Holdings, Inc. (collectively, “Rockwood”), Albemarle Corporation (as Rockwood’s successor) (“Albemarle”) and certain former Rockwood executives to recover damages for fraud and breach of contract in connection with our purchase of Rockwood’s pigments businesses, including its Color Pigments Division, for $1.1 billion in 2014. The case was ordered to arbitration under the rules of the American Arbitration Association and, after a two-week trial in May 2021, a panel consisting of three former federal judges awarded us in excess of $600 million for the fraud and breach, inclusive of punitive damages and statutory interest at 9%, of which we expect to net in excess of $400 million after attorney’s fees. The award is subject to confirmation and limited appeal in New York state court, and the arbitration panel directed us to file for reimbursement from Albemarle for attorney’s fees as prevailing party.

On July 26, 2021, the Attorney General of the State of Texas filed a civil suit in the District Court of Travis County, Texas seeking civil penalties and attorney’s fees for alleged violations of the Texas Clean Air Act, Texas Commission on Environmental Quality regulations and facility permit terms. The complaint alleged multiple unauthorized emissions events and reporting discrepancies that occurred between December 2016 and June 2019 at our former manufacturing facility in Port Neches, Texas. The state is seeking monetary relief between $250,000 and $1 million. We completed the sale of our former Port Neches, Texas facility to Indorama Ventures Holdings L.P. on January 3, 2020. We believe that we are contractually indemnified for any defense costs and potential liability that may result from this action.

For information regarding risk factors, see “Part I. Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020.

The following table provides information with respect to shares of our common stock that we repurchased as part of our share repurchase program and shares of restricted stock granted under our stock incentive plans that we withheld upon vesting to satisfy our tax withholding obligations during the three months ended ~~March 31,~~September 30, 2021.

5057

Table of Contents

See the Exhibit Index at the end of this Quarterly Report on Form 10-Q for exhibits filed with this report.

5158

Table of Contents

5259

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

		Page
PART I	FINANCIAL INFORMATION	4
ITEM 1.	Condensed Consolidated Financial Statements (Unaudited)	4
	Huntsman Corporation and Subsidiaries:
	Condensed Consolidated Balance Sheets	4
	Condensed Consolidated Statements of Operations	5
	Condensed Consolidated Statements of Comprehensive Income	6
	Condensed Consolidated Statements of Equity	7
	Condensed Consolidated Statements of Cash Flows	89
	Huntsman International LLC and Subsidiaries:
	Condensed Consolidated Balance Sheets	1011
	Condensed Consolidated Statements of Operations	1112
	Condensed Consolidated Statements of Comprehensive Income	1213
	Condensed Consolidated Statements of Equity	1314
	Condensed Consolidated Statements of Cash Flows	1415
	Huntsman Corporation and Subsidiaries and Huntsman International LLC and Subsidiaries:
	Notes to Condensed Consolidated Financial Statements	1617
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3639
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	4956
ITEM 4.	Controls and Procedures	4956
PART II	OTHER INFORMATION	5057
ITEM 1.	Legal Proceedings	5057
ITEM 1A.	Risk Factors	5057
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	5057
ITEM 6.	Exhibits	5158

	*March 31,*			*December 31,*			*September 30,*			*December 31,*
	*2021*			*2020*			*2021*			*2020*
ASSETS
Current assets:
Cash and cash equivalents(a)	$	673		$	1,593		$	505		$	1,593
Accounts and notes receivable (net of allowance for doubtful accounts of $26 for both), ($245 and $198 pledged as collateral, respectively)(a)		1,010			902
Accounts and notes receivable (net of allowance for doubtful accounts of $25 and $26, respectively), ($336 and $198 pledged as collateral, respectively)(a)								1,216			902
Accounts receivable from affiliates		12			8			23			8
Inventories(a)		1,006			848			1,174			848
Other current assets		228			217			196			217
Total current assets		2,929			3,568			3,114			3,568
Property, plant and equipment, net(a)		2,514			2,505			2,540			2,505
Investment in unconsolidated affiliates		411			373			466			373
Intangible assets, net		422			453			404			453
Goodwill		739			533			741			533
Deferred income taxes		282			288			281			288
Operating lease right-of-use assets		432			445			418			445
Other noncurrent assets(a)		571			548			605			548
Total assets	$	8,300		$	8,713		$	8,569		$	8,713

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	909		$	842		$	955		$	842
Accounts payable to affiliates		44			34			30			34
Accrued liabilities(a)		505			458			569			458
Current portion of debt(a)		57			593			16			593
Current operating lease liabilities(a)		49			52			54			52
Total current liabilities		1,564			1,979			1,624			1,979
Long-term debt(a)		1,510			1,528			1,567			1,528
Deferred income taxes		216			212			201			212
Noncurrent operating lease liabilities(a)		401			411			383			411
Other noncurrent liabilities(a)		875			910			840			910
Total liabilities		4,566			5,040			4,615			5,040
Commitments and contingencies (Notes 15 and 16)
Equity
Huntsman Corporation stockholders’ equity:
Common stock $0.01 par value, 1,200,000,000 shares authorized, 259,184,140 and 258,520,411 shares issued and 220,712,124 and 220,046,262 shares outstanding, respectively		3			3
Common stock $0.01 par value, 1,200,000,000 shares authorized, 259,468,984 and 258,520,411 shares issued and 217,028,320 and 220,046,262 shares outstanding, respectively								3			3
Additional paid-in capital		4,085			4,048			4,096			4,048
Treasury stock, 38,477,091 shares		(731	)		(731	)
Treasury stock, 42,448,875 and 38,477,091 shares, respectively								(833	)		(731	)
Unearned stock-based compensation		(38	)		(19	)		(30	)		(19	)
Retained earnings		1,603			1,564			1,881			1,564
Accumulated other comprehensive loss		(1,359	)		(1,346	)		(1,338	)		(1,346	)
Total Huntsman Corporation stockholders’ equity		3,563			3,519			3,779			3,519
Noncontrolling interests in subsidiaries		171			154			175			154
Total equity		3,734			3,673			3,954			3,673
Total liabilities and equity	$	8,300		$	8,713		$	8,569		$	8,713

	*Three months*						*Three months*						*Nine months*
	*ended*						*ended*						*ended*
	*March 31,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2021*			*2020*
Revenues:
Trade sales, services and fees, net	$	1,802		$	1,549		$	2,230		$	1,487		$	6,006		$	4,262
Related party sales		35			44			55			23			140			88
Total revenues		1,837			1,593			2,285			1,510			6,146			4,350
Cost of goods sold		1,445			1,296			1,802			1,231			4,840			3,612
Gross profit		392			297			483			279			1,306			738
Operating expenses:
Selling, general and administrative		207			199			204			178			620			563
Research and development		38			36			38			33			113			101
Restructuring, impairment and plant closing costs		24			3
Other operating (income) expense, net		(3	)		5
Restructuring, impairment and plant closing (credits) costs								(1	)		12			34			34
Gain on sale of India-based DIY business								0			0			(28	)		0
Other operating income, net								(3	)		(3	)		(13	)		(4	)
Total operating expenses		266			243			238			220			726			694
Operating income		126			54			245			59			580			44
Interest expense, net		(19	)		(18	)		(15	)		(24	)		(52	)		(63	)
Equity in income of investment in unconsolidated affiliates		38			2			34			21			118			25
Fair value adjustments to Venator investment		(19	)		(110	)		(3	)		6			(28	)		(100	)
Loss on early extinguishment of debt								0			0			(27	)		0
Other income, net		7			10			7			10			23			27
Income (loss) from continuing operations before income taxes		133			(62	)		268			72			614			(67	)
Income tax expense		(34	)		(7	)		(38	)		(15	)		(114	)		(9	)
Income (loss) from continuing operations		99			(69	)		230			57			500			(76	)
Income from discontinued operations, net of tax		1			777
(Loss) income from discontinued operations, net of tax								(5	)		0			(3	)		782
Net income		100			708			225			57			497			706
Net income attributable to noncontrolling interests		(17	)		(3	)		(16	)		(9	)		(49	)		(15	)
Net income attributable to Huntsman Corporation	$	83		$	705		$	209		$	48		$	448		$	691

Basic income per share:
Basic income (loss) per share:
Income (loss) from continuing operations attributable to Huntsman Corporation common stockholders	$	0.38		$	(0.32	)	$	0.97		$	0.22		$	2.04		$	(0.41	)
Income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		0			3.48
(Loss) income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax								(0.02	)		0			(0.01	)		3.54
Net income attributable to Huntsman Corporation common stockholders	$	0.38		$	3.16		$	0.95		$	0.22		$	2.03		$	3.13
Weighted average shares		220.4			223.2			219.4			219.8			220.2			220.8

Diluted income per share:
Diluted income (loss) per share:
Income (loss) from continuing operations attributable to Huntsman Corporation common stockholders	$	0.37		$	(0.32	)	$	0.96		$	0.22		$	2.03		$	(0.41	)
Income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax		0			3.48
(Loss) income from discontinued operations attributable to Huntsman Corporation common stockholders, net of tax								(0.02	)		0			(0.01	)		3.54
Net income attributable to Huntsman Corporation common stockholders	$	0.37		$	3.16		$	0.94		$	0.22		$	2.02		$	3.13
Weighted average shares		222.6			223.2			221.3			221.3			222.2			220.8

Amounts attributable to Huntsman Corporation common stockholders:
Income (loss) from continuing operations	$	82		$	(72	)	$	214		$	48		$	451		$	(91	)
Income from discontinued operations, net of tax		1			777
(Loss) income from discontinued operations, net of tax								(5	)		0			(3	)		782
Net income	$	83		$	705		$	209		$	48		$	448		$	691

	*March 31,*			*December 31,*			September 30,			December 31,
	*2021*			*2020*			2021			2020
ASSETS
Current assets:
Cash and cash equivalents(a)	$	667		$	1,591		$	505		$	1,591
Accounts and notes receivable (net of allowance for doubtful accounts of $26 for both), ($245 and $198 pledged as collateral, respectively)(a)		1,010			902
Accounts and notes receivable (net of allowance for doubtful accounts of $25 and $26, respectively), ($336 and $198 pledged as collateral, respectively)(a)								1,216			902
Accounts receivable from affiliates		59			47			167			47
Inventories(a)		1,006			848			1,174			848
Other current assets		227			223			194			223
Total current assets		2,969			3,611			3,256			3,611
Property, plant and equipment, net(a)		2,514			2,505			2,540			2,505
Investment in unconsolidated affiliates		411			373			466			373
Intangible assets, net		422			453			404			453
Goodwill		739			533			741			533
Deferred income taxes		282			288			281			288
Operating lease right-of-use assets		432			445			418			445
Other noncurrent assets(a)		569			548			604			548
Total assets	$	8,338		$	8,756		$	8,710		$	8,756

LIABILITIES AND EQUITY
Current liabilities:
Accounts payable(a)	$	908		$	842		$	954		$	842
Accounts payable to affiliates		46			36			32			36
Accrued liabilities(a)		496			455			559			455
Current portion of debt(a)		57			593			16			593
Current operating lease liabilities(a)		49			52			54			52
Total current liabilities		1,556			1,978			1,615			1,978
Long-term debt(a)		1,510			1,528			1,567			1,528
Deferred income taxes		217			214			203			214
Noncurrent operating lease liabilities(a)		401			411			383			411
Other noncurrent liabilities(a)		867			900			831			900
Total liabilities		4,551			5,031			4,599			5,031
Commitments and contingencies (Notes 15 and 16)
Equity
Huntsman International LLC members’ equity:
Members’ equity, 2,728 units issued and outstanding		3,709			3,701			3,724			3,701
Retained earnings		1,252			1,203			1,536			1,203
Accumulated other comprehensive loss		(1,345	)		(1,333	)		(1,324	)		(1,333	)
Total Huntsman International LLC members’ equity		3,616			3,571			3,936			3,571
Noncontrolling interests in subsidiaries		171			154			175			154
Total equity		3,787			3,725			4,111			3,725
Total liabilities and equity	$	8,338		$	8,756		$	8,710		$	8,756

	*Three months*						*Nine months*
	*ended*						*ended*
	*March 31,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*
Financing Activities:
Net borrowings (repayments) on revolving loan facilities	$	9		$	(158	)	$	8		$	(153	)
Proceeds from issuance of long-term debt								427			0
Repayments of long-term debt		(548	)		0			(965	)		(17	)
Repayments of short-term debt								0			(109	)
Repayments of notes payable to affiliate		0			(380	)		0			(380	)
Repayments of notes payable		0			(32	)		0			(32	)
Debt issuance costs paid								(4	)		0
Dividends paid to noncontrolling interests		0			(23	)		(30	)		(23	)
Dividends paid to parent		(36	)		(36	)		(118	)		(109	)
Other		0			(2	)
Costs of early extinguishment of debt								(26	)		0
Other, net								2			(1	)
Net cash used in financing activities		(575	)		(631	)		(706	)		(824	)
Effect of exchange rate changes on cash		(1	)		(13	)		(2	)		(4	)
(Decrease) increase in cash, cash equivalents and restricted cash		(924	)		1,069			(1,086	)		642
Cash, cash equivalents and restricted cash at beginning of period		1,591			525			1,591			525
Cash, cash equivalents and restricted cash at end of period	$	667		$	1,594		$	505		$	1,167

Supplemental cash flow information:
Cash paid for interest	$	16		$	5		$	57		$	49
Cash paid for income taxes		8			36			83			242

	*Huntsman Corporation Stockholders' Equity*																								*Huntsman Corporation Stockholders' Equity*
																	*Accumulated*																								*Accumulated*
	*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*					*Shares*					*Additional*					*Unearned*						*other*			*Noncontrolling*
	*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*		*Total*			*common*			*Common*		*paid-in*		*Treasury*			*stock-based*			*Retained*			*comprehensive*			*interests in*			*Total*
	*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*		*equity*			*stock*			*stock*		*capital*		*stock*			*compensation*			*earnings*			*loss*			*subsidiaries*			*equity*
Balance, January 1, 2021		220,046,262		$	3	$	4,048	$	(731	)	$	(19	)	$	1,564		$	(1,346	)	$	154	$	3,673			220,046,262		$	3	$	4,048	$	(731	)	$	(19	)	$	1,564		$	(1,346	)	$	154		$	3,673
Net income		—			0		0		0			0			83			0			17		100			—			0		0		0			0			83			0			17			100
Other comprehensive loss		—			0		0		0			0			0			(13	)		0		(13	)		—			0		0		0			0			0			(13	)		0			(13	)
Issuance of nonvested stock awards		—			0		25		0			(25	)		0			0			0		0			—			0		25		0			(25	)		0			0			0			0
Vesting of stock awards		664,818			0		5		0			0			0			0			0		5			664,818			0		5		0			0			0			0			0			5
Recognition of stock-based compensation		—			0		2		0			6			0			0			0		8			—			0		2		0			6			0			0			0			8
Repurchase and cancellation of stock awards		(202,961	)		0		0		0			0			(6	)		0			0		(6	)		(202,961	)		0		0		0			0			(6	)		0			0			(6	)
Stock options exercised		204,005			0		5		0			0			(2	)		0			0		3			204,005			0		5		0			0			(2	)		0			0			3
Dividends declared on common stock ($0.1625 per share)		—			0		0		0			0			(36	)		0			0		(36	)
Dividends declared on common stock ($0.1625 per share)																										—			0		0		0			0			(36	)		0			0			(36	)
Balance, March 31, 2021		220,712,124		$	3	$	4,085	$	(731	)	$	(38	)	$	1,603		$	(1,359	)	$	171	$	3,734			220,712,124		$	3	$	4,085	$	(731	)	$	(38	)	$	1,603		$	(1,359	)	$	171		$	3,734
Net income																										—			0		0		0			0			156			0			16			172
Other comprehensive income																										—			0		0		0			0			0			41			1			42
Vesting of stock awards																										3,732			0		0		0			0			0			0			0			0
Recognition of stock-based compensation																										—			0		2		0			4			0			0			0			6
Repurchase and cancellation of stock awards																										(19,912	)		0		0		0			0			(1	)		0			0			(1	)
Stock options exercised																										263,962			0		6		0			0			(3	)		0			0			3
Dividends declared to noncontrolling interests																										—			0		0		0			0			0			0			(30	)		(30	)
Dividends declared on common stock ($0.1875 per share)																										—			0		0		0			0			(41	)		0			0			(41	)
Balance, June 30, 2021																										220,959,906		$	3	$	4,093	$	(731	)	$	(34	)	$	1,714		$	(1,318	)	$	158		$	3,885
Net income																										—			0		0		0			0			209			0			16			225
Other comprehensive (loss) income																										—			0		0		0			0			0			(20	)		1			(19	)
Issuance of nonvested stock awards																										—			0		1		0			(1	)		0			0			0			0
Vesting of stock awards																										7,695			0		0		0			0			0			0			0			0
Recognition of stock-based compensation																										—			0		1		0			5			0			0			0			6
Repurchase and cancellation of stock awards																										(1,869	)		0		0		0			0			0			0			0			0
Stock options exercised																										34,372			0		1		0			0			0			0			0			1
Treasury stock repurchased																										(3,971,784	)		0		0		(102	)		0			0			0			0			(102	)
Dividends declared on common stock ($0.1875 per share)																										—			0		0		0			0			(42	)		0			0			(42	)
Balance, September 30, 2021																										217,028,320		$	3	$	4,096	$	(833	)	$	(30	)	$	1,881		$	(1,338	)	$	175		$	3,954

	*Huntsman International LLC Members*
	*Members'*							*Accumulated other*			*Noncontrolling*
	*equity*							*comprehensive*			*interests in*		*Total*
	*Units*		*Amount*		*Retained earnings*			*loss*			*subsidiaries*		*equity*
Balance, January 1, 2021		2,728	$	3,701	$	1,203		$	(1,333	)	$	154	$	3,725
Net income		—		0		85			0			17		102
Dividends paid to parent		—		0		(36	)		0			0		(36	)
Other comprehensive loss		—		0		0			(12	)		0		(12	)
Contribution from parent		—		8		0			0			0		8
Balance, March 31, 2021		2,728	$	3,709	$	1,252		$	(1,345	)	$	171	$	3,787

Fair value of assets acquired and liabilities assumed:
Cash paid for the Gabriel Acquisition	$	249		$	251

Cash	$	9		$	9
Accounts receivable		13			13
Inventories		26			26
Property, plant and equipment		23			23
Intangible assets		16			16
Goodwill		172			174
Accounts payable		(7	)		(7	)
Accrued liabilities		(2	)		(2	)
Deferred income taxes		(1	)		(1	)
Total fair value of net assets acquired	$	249		$	251

Fair value of assets acquired and liabilities assumed:
Cash paid for the CVC Thermoset Specialties Acquisition	$	304

Accounts receivable	$	12
Inventories		37
Property, plant and equipment		67
Intangible assets		117
Goodwill		120
Accounts payable		(7	)
Accrued liabilities		(1	)
Deferred income taxes		(41	)
Total fair value of net assets acquired	$	304

Fair value of assets acquired and liabilities assumed:
Cash paid for the Icynene-Lapolla Acquisition in Q1 2020	$	353
Cash paid for the Icynene-Lapolla Acquisition				$	353

Cash	$	7		$	7
Accounts receivable		36			36
Inventories		32			32
Prepaid expenses and other current assets		2			2
Property, plant and equipment		9			9
Intangible assets		130			130
Goodwill		167			167
Other noncurrent assets		4			4
Accounts payable		(14	)		(14	)
Accrued liabilities		(11	)		(11	)
Deferred income taxes		(9	)		(9	)
Total fair value of net assets acquired	$	353		$	353

	*Three months*
	*ended*
	*March 31, 2020*
Revenues	$	532
Gross profit		61
Income from continuing operations		8
Net income		8
Net income attributable to Venator		7

							*Other Postretirement*												*Other Postretirement*
	*Defined Benefit Plans*						*Benefit Plans*						*Defined Benefit Plans*						*Benefit Plans*
	*Three months*						*Three months*						*Three months*						*Three months*
	*ended*						*ended*						*ended*						*ended*
	*March 31,*						*March 31,*						*September 30,*						*September 30,*
	*2021*			*2020*			*2021*			*2020*			*2021*			*2020*			*2021*			*2020*
Service cost	$	14		$	14		$	0		$	0		$	13		$	13		$	1		$	0
Interest cost		12			15			0			1			13			15			0			1
Expected return on assets		(42	)		(43	)		0			0			(42	)		(44	)		0			0
Amortization of prior service benefit		(2	)		(2	)		(1	)		(1	)		(2	)		(2	)		(1	)		(2	)
Amortization of actuarial loss		23			20			1			0			23			21			0			1
Settlement loss		3			0			0			0
Net periodic benefit cost	$	8		$	4		$	0		$	0		$	5		$	3		$	0		$	0

				*Pension*			*Other*															*Pension*			*Other*
	*Foreign*			*and other*			*comprehensive*							*Amounts*		*Amounts*			*Foreign*			*and other*			*comprehensive*							*Amounts*			*Amounts*
	*currency*			*postretirement*			*income of*							*attributable to*		*attributable to*			*currency*			*postretirement*			*income of*							*attributable to*			*attributable to*
	*translation*			*benefits*			*unconsolidated*							*noncontrolling*		*Huntsman*			*translation*			*benefits*			*unconsolidated*							*noncontrolling*			*Huntsman*
	*adjustment(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*		*Corporation*			*adjustment(a)*			*adjustments(b)*			*affiliates*		*Other, net*		*Total*			*interests*			*Corporation*
Beginning balance, January 1, 2021	$	(328	)	$	(1,050	)	$	8	$	4	$	(1,366	)	$	20	$	(1,346	)	$	(328	)	$	(1,050	)	$	8	$	4	$	(1,366	)	$	20		$	(1,346	)
Other comprehensive loss before reclassifications, gross		(32	)		0			0		0		(32	)		0		(32	)		(42	)		0			0		0		(42	)		(2	)		(44	)
Tax expense		0			0			0		0		0			0		0			0			0			0		0		0			0			0
Amounts reclassified from accumulated other comprehensive loss, gross(c)		0			24			0		0		24			0		24			0			65			0		0		65			0			65
Tax expense		0			(5	)		0		0		(5	)		0		(5	)		0			(13	)		0		0		(13	)		0			(13	)
Net current-period other comprehensive (loss) income		(32	)		19			0		0		(13	)		0		(13	)		(42	)		52			0		0		10			(2	)		8
Ending balance, March 31, 2021	$	(360	)	$	(1,031	)	$	8	$	4	$	(1,379	)	$	20	$	(1,359	)
Ending balance, September 30, 2021																			$	(370	)	$	(998	)	$	8	$	4	$	(1,356	)	$	18		$	(1,338	)

	*Three Months Ended March 31,*
	*2021*			*2020*
	*Amounts reclassified*			*Amounts reclassified*			*Affected line item in*
	*from accumulated*			*from accumulated*			*the statement*
Details about Accumulated Other	*other*			*other*			*where net income*
Comprehensive Loss Components(a):	*comprehensive loss*			*comprehensive loss*			*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(3	)	$	(3	)	(b)
Settlement loss		3			41		(c)
Actuarial loss		24			20		(b)(d)
		24			58		Total before tax
		(5	)		(14	)	Income tax expense
Total reclassifications for the period	$	19		$	44		Net of tax

	*Three Months Ended September 30,*
	*2021*			*2020*
	*Amounts reclassified*			*Amounts reclassified*			*Affected line item in*
	*from accumulated*			*from accumulated*			*the statement*
Details about Accumulated Other	*other*			*other*			*where net income*
Comprehensive Loss Components(a):	*comprehensive loss*			*comprehensive loss*			*is presented*
Amortization of pension and other postretirement benefits:		��
Prior service credit	$	(3	)	$	(3	)	(b)
Actuarial loss		23			21		(b)(d)
		20			18		Total before tax
		(3	)		(4	)	Income tax expense
Total reclassifications for the period	$	17		$	14		Net of tax

	*Nine Months Ended September 30,*
	*2021*			*2020*
	*Amounts reclassified*			*Amounts reclassified*			*Affected line item in*
	*from accumulated*			*from accumulated*			*the statement*
Details about Accumulated Other	*other*			*other*			*where net income*
Comprehensive Loss Components(a):	*comprehensive loss*			*comprehensive loss*			*is presented*
Amortization of pension and other postretirement benefits:
Prior service credit	$	(8	)	$	(9	)	(b)
Settlement loss		3			41		(c)
Actuarial loss		70			61		(b)(d)
		65			93		Total before tax
		(13	)		(21	)	Income tax expense
Total reclassifications for the period	$	52		$	72		Net of tax

						*Weighted*									*Weighted*
				*Weighted*		*Average*							*Weighted*		*Average*
				*Average*		*Remaining*		*Aggregate*					*Average*		*Remaining*		*Aggregate*
				*Exercise*		*Contractual*		*Intrinsic*					*Exercise*		*Contractual*		*Intrinsic*
Option Awards	*Shares*			*Price*		*Term*		*Value*		*Shares*			*Price*		*Term*		*Value*
	(in thousands)					(years)		(in millions)		(in thousands)					(years)		(in millions)
Outstanding at January 1, 2021		4,815		$	20.37						4,815		$	20.37
Granted		304			28.58						304			28.58
Exercised		(275	)		17.94						(697	)		17.44
Forfeited		(21	)		28.12						(71	)		24.29
Outstanding at March 31, 2021		4,823			20.99		6.2	$	39
Exercisable at March 31, 2021		3,729			20.17		5.4		34
Outstanding at September 30, 2021											4,351			21.35		5.8	$	37
Exercisable at September 30, 2021											3,309			20.59		5.0		31

	*Equity Awards*						*Liability Awards*					*Equity Awards*						*Liability Awards*
					*Weighted*					*Weighted*						*Weighted*					*Weighted*
					*Average*					*Average*						*Average*					*Average*
					*Grant-Date*					*Grant-Date*						*Grant-Date*					*Grant-Date*
	*Shares*				*Fair Value*		*Shares*			*Fair Value*		*Shares*				*Fair Value*		*Shares*			*Fair Value*
	(in thousands)						(in thousands)					(in thousands)						(in thousands)
Nonvested at January 1, 2021		1,867			$	23.18		411		$	23.08		1,867			$	23.18		411		$	23.08
Granted		831				31.17		184			28.58		856				31.06		184			28.58
Vested		(512	)	⁽¹⁾⁽²⁾		28.26		(188	)		24.59		(521	)	⁽¹⁾⁽²⁾		28.19		(189	)		24.55
Forfeited		(6	)			21.89		(4	)		22.88		(17	)			23.96		(20	)		24.18
Nonvested at March 31, 2021		2,180				25.04		403			24.89
Nonvested at September 30, 2021													2,185				25.07		386			24.92

Segment		Products
Polyurethanes		MDI, polyols, TPU and other polyurethane-related products
Performance Products		Specialty amines, ethyleneamines, maleic anhydride and technology licenses
Advanced Materials		Basic liquid and solid epoxy resins; specialty resin compounds; cross-linking, matting, and curing and toughening agents; epoxy, acrylic and polyurethane-based formulations; specialty nitrile latex, alkyd resins and carbon nano materials
Textile Effects		Textile chemicals and dyes

	●	~~Continued recovery in core markets as well as favorable~~Favorable trends in sustainable solutions
	●	Pricing increases to offset raw material cost increases

	Three months									Three months									Nine months
	ended									ended									ended
	March 31,						Percent			September 30,						Percent			September 30,						Percent
	2021			2020			Change			2021			2020			Change			2021			2020			Change
Revenues	$	1,837		$	1,593			15	%	$	2,285		$	1,510			51	%	$	6,146		$	4,350			41	%
Cost of goods sold		1,445			1,296			11	%		1,802			1,231			46	%		4,840			3,612			34	%
Gross profit		392			297			32	%		483			279			73	%		1,306			738			77	%
Operating expenses		242			240			1	%
Restructuring, impairment and plant closing costs		24			3			700	%
Operating expenses, net											239			208			15	%		692			660			5	%
Restructuring, impairment and plant closing (credits) costs											(1	)		12			NM			34			34			—
Operating income		126			54			133	%		245			59			315	%		580			44			NM
Interest expense, net		(19	)		(18	)		6	%		(15	)		(24	)		(38	)%		(52	)		(63	)		(17	)%
Equity in income of investment in unconsolidated affiliates		38			2			NM			34			21			62	%		118			25			372	%
Fair value adjustments to Venator investment		(19	)		(110	)		(83	)%		(3	)		6			NM			(28	)		(100	)		(72	)%
Loss on early extinguishment of debt											—			—			—			(27	)		—			NM
Other income, net		7			10			(30	)%		7			10			(30	)%		23			27			(15	)%
Income (loss) from continuing operations before income taxes		133			(62	)		NM			268			72			272	%		614			(67	)		NM
Income tax expense		(34	)		(7	)		386	%		(38	)		(15	)		153	%		(114	)		(9	)		NM
Income (loss) from continuing operations		99			(69	)		NM			230			57			304	%		500			(76	)		NM
Income from discontinued operations, net of tax		1			777			(100	)%
(Loss) income from discontinued operations, net of tax(1)											(5	)		—			NM			(3	)		782			NM
Net income		100			708			(86	)%		225			57			295	%		497			706			(30	)%
Reconciliation of net income to adjusted EBITDA:
Net income attributable to noncontrolling interests		(17	)		(3	)		467	%		(16	)		(9	)		78	%		(49	)		(15	)		227	%
Interest expense, net from continuing operations		19			18			6	%		15			24			(38	)%		52			63			(17	)%
Income tax expense from continuing operations		34			7			386	%		38			15			153	%		114			9			NM
Income tax expense from discontinued operations		—			238			NM			5			—			NM			5			239			(98	)%
Depreciation and amortization of continuing operations		74			67			10	%		72			70			3	%		219			206			6	%
Other adjustments:
Business acquisition and integration expenses and purchase accounting inventory adjustments		9			13						5			9						19			30
EBITDA from discontinued operations(1)		(1	)		(1,015	)					—			—						(2	)		(1,021	)
Fair value adjustments to Venator investment		19			110						3			(6	)					28			100
Certain legal and other settlements and related expenses		2			2
Loss on early extinguishment of debt											—			—						27			—
Certain legal and other settlements and related (income) expenses											—			(4	)					10			2
Gain on sale of businesses/assets		—			(2	)					—			—						(30	)		(1	)
Income from transition services arrangements		(1	)		—						(2	)		(1	)					(6	)		(6	)
Certain nonrecurring information technology project implementation costs		1			1						2			1						6			3
Amortization of pension and postretirement actuarial losses		22			18						22			20						65			57
Plant incident remediation costs		4			—						2			—						3			1
Restructuring, impairment and plant closing and transition costs		24			3						—			12						36			34
Adjusted EBITDA(2)	$	289		$	165			75	%	$	371		$	188			97	%	$	994		$	407			144	%

Net cash used in operating activities from continuing operations	$	(16	)	$	(40	)		(60	)%
Net cash provided by operating activities from continuing operations																			$	163		$	110			48	%
Net cash (used in) provided by investing activities		(323	)		1,511			NM												(439	)		1,105			NM
Net cash used in financing activities		(579	)		(354	)		64	%											(809	)		(546	)		48	%
Capital expenditures		(98	)		(61	)		61	%											(250	)		(170	)		47	%

	Three months ended March 31, 2021 vs 2020												Three months ended September 30, 2021 vs 2020
	Average Selling Price(1)												Average Selling Price(1)
	Local			Foreign Currency			Mix &			Sales			Local			Foreign Currency			Mix &			Sales
	Currency			Translation Impact			Other			Volumes(2)			Currency			Translation Impact			Other			Volumes(2)
Period-Over-Period Increase (Decrease)
Polyurethanes		17	%		3	%		—			—			40	%		2	%		6	%		2	%
Performance Products		6	%		4	%		(3	)%		(3	)%		49	%		2	%		(8	)%		25	%
Advanced Materials		5	%		5	%		8	%		(3	)%		23	%		3	%		24	%		3	%
Textile Effects		(7	)%		1	%		3	%		10	%		15	%		3	%		(2	)%		16	%

	Three months ended March 31, 2021 vs December 31, 2020												Three months ended September 30, 2021 vs June 30, 2021
	Average Selling Price(1)												Average Selling Price(1)
	Local			Foreign Currency			Mix &			Sales			Local			Foreign Currency			Mix &			Sales
	Currency			Translation Impact			Other			Volumes(2)			Currency			Translation Impact			Other			Volumes(2)
Period-Over-Period (Decrease) Increase
Polyurethanes		7	%		2	%		3	%		(8	)%		8	%		(1	)%		4	%		10	%
Performance Products		11	%		1	%		(2	)%		5	%		8	%		(1	)%		2	%		(1	)%
Advanced Materials		5	%		6	%		9	%		14	%		5	%		—			1	%		(4	)%
Textile Effects		3	%		2	%		1	%		6	%		—			—			(2	)%		(7	)%

	Nine months ended September 30, 2021 vs September 30, 2020
	Average Selling Price(1)
	Local			Foreign Currency			Mix &			Sales
	Currency			Translation Impact			Other			Volumes(2)
Period-Over-Period (Decrease) Increase
Polyurethanes		31	%		3	%		4	%		4	%
Performance Products		29	%		4	%		(5	)%		14	%
Advanced Materials		10	%		5	%		11	%		13	%
Textile Effects		(1	)%		3	%		5	%		32	%

	March 31,		Less					December 31,		Increase			Percent			September 30,		Less					December 31,		(Decrease)			Percent
	2021		Acquisitions(1)			Subtotal		2020		(Decrease)			Change			2021		Acquisition(1)			Subtotal		2020		Increase			Change
Cash and cash equivalents	$	673	$	(9	)	$	664	$	1,593	$	(929	)		(58	)%	$	505	$	(9	)	$	496	$	1,593	$	(1,097	)		(69	)%
Accounts and notes receivable, net		1,022		(13	)		1,009		910		99			11	%		1,239		(13	)		1,226		910		316			35	%
Inventories		1,006		(26	)		980		848		132			16	%		1,174		(26	)		1,148		848		300			35	%
Other current assets		228		—			228		217		11			5	%		196		—			196		217		(21	)		(10	)%
Total current assets		2,929		(48	)		2,881		3,568		(687	)		(19	)%		3,114		(48	)		3,066		3,568		(502	)		(14	)%
Accounts payable		953		(7	)		946		876		70			8	%		985		(7	)		978		876		102			12	%
Accrued liabilities		505		(2	)		503		458		45			10	%		569		(2	)		567		458		109			24	%
Current portion of debt		57		—			57		593		(536	)		(90	)%		16		—			16		593		(577	)		(97	)%
Current operating lease liabilities		49		—			49		52		(3	)		(6	)%		54		—			54		52		2			4	%
Total current liabilities		1,564		(9	)		1,555		1,979		(424	)		(21	)%		1,624		(9	)		1,615		1,979		(364	)		(18	)%
Working capital	$	1,365	$	(39	)	$	1,326	$	1,589	$	(263	)		(17	)%	$	1,490	$	(39	)	$	1,451	$	1,589	$	(138	)		(9	)%

					Total number of		Approximate dollar
					shares purchased		value of shares that
	Total number		Average		as part of publicly		may yet be purchased
	of shares		price paid		announced plans		under the plans or
	purchased		per share(1)		or programs(2)		programs(2)
January		—	$	—		—	$	420,000,000
February		141,109		28.46		—		420,000,000
March		318		26.28		—		420,000,000
Total		141,427		28.45		—

			~~Incorporated by Reference~~
~~Exhibit Number~~		~~Exhibit Description~~	~~Form~~	~~Exhibit~~	~~Filing Date~~
~~31.1~~	*	~~Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~
~~31.2~~	*	~~Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~
~~32.1~~	*	~~Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~
~~32.2~~	*	~~Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~
~~101.INS~~	*	~~Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document~~
~~101.SCH~~	*	~~Inline XBRL Taxonomy Extension Schema~~
~~101.CAL~~	*	~~Inline XBRL Taxonomy Extension Calculation Linkbase~~
~~101.LAB~~	*	~~Inline XBRL Taxonomy Extension Label Linkbase~~
~~101.PRE~~	*	~~Inline XBRL Taxonomy Extension Presentation Linkbase~~
~~101.DEF~~	*	~~Inline XBRL Taxonomy Extension Definition Linkbase~~
~~104~~		~~The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101~~

			Incorporated by Reference
Exhibit Number		Exhibit Description	Form	Exhibit	Filing Date
10.1		Master Amendment No. 10 to U.S. Receivables Loan Agreement, U.S. Servicing Agreement, U.S. Receivables Purchase Agreement and Transaction Documents, dated as of July 1, 2021	10-Q	10.1	July 30, 2021
10.2		Amended and Restated European Receivables Loan Agreement, dated as of July 1, 2021	10-Q	10.2	July 30, 2021
10.3	*	Independent Services Agreement No. ISA-SD-2021 (Sean Douglas)
31.1	*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	*	Certification of Chief Executive Office r pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	*	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	*	Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	*	Inline XBRL Taxonomy Extension Schema
101.CAL	*	Inline XBRL Taxonomy Extension Calculation Linkbase
101.LAB	*	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	*	Inline XBRL Taxonomy Extension Presentation Linkbase
101.DEF	*	Inline XBRL Taxonomy Extension Definition Linkbase
104		The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL and contained in Exhibit 101

Dated: ~~April 30,~~October 29, 2021	HUNTSMAN CORPORATION
	HUNTSMAN INTERNATIONAL LLC

	By:	/s/ ~~SEAN DOUGLAS~~PHILIP M. LISTER
		~~Sean Douglas~~Philip M. Lister
		Executive Vice President and Chief Financial Officer
		and Manager (Principal Financial Officer)

	By:	/s/ ~~RANDY W. WRIGHT~~ STEVEN C. JORGENSEN
		~~Randy W. Wright~~ Steven C. Jorgensen
		Vice President and Controller (Authorized Signatory and
		Principal Accounting Officer)